KR101346281B1 - Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient - Google Patents

Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient Download PDF

Info

Publication number
KR101346281B1
KR101346281B1 KR1020130098557A KR20130098557A KR101346281B1 KR 101346281 B1 KR101346281 B1 KR 101346281B1 KR 1020130098557 A KR1020130098557 A KR 1020130098557A KR 20130098557 A KR20130098557 A KR 20130098557A KR 101346281 B1 KR101346281 B1 KR 101346281B1
Authority
KR
South Korea
Prior art keywords
weight
gout
preventing
extract
silver
Prior art date
Application number
KR1020130098557A
Other languages
Korean (ko)
Inventor
황정만
강영효
Original Assignee
강영효
황정만
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 강영효, 황정만 filed Critical 강영효
Priority to KR1020130098557A priority Critical patent/KR101346281B1/en
Application granted granted Critical
Publication of KR101346281B1 publication Critical patent/KR101346281B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/539Scutellaria (skullcap)
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/32Burseraceae (Frankincense family)
    • A61K36/328Commiphora, e.g. mecca myrrh or balm of Gilead
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/06Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Botany (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Neurosurgery (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to compositions for preventing, improving, or treating gout, containing extracts of twenty nine medicine plants as an active ingredient. More particularly, the present invention relates to compositions for preventing, improving, or treating gout, the compositions containing, as an active ingredient, extracts of gold, Lonicera japonica, Actinidiapolygama, myrrh, Siegesbeckia, Chaenomeles sinensis, Angelica dahurica root, Schizonepetae Spica, poncirus, kalopanx, taraxacum herb, Clematis florida, Bambusae caulis, corydaline, safflower, cnidium, achyranthes, Atractylodes macrocephala, dried orange peel, white atractylis, forsythia fruit, Rehmannia glutinosa, Poria cocos Wolf, licorice, platycodon, Korean aralia root, coix, Sinapis alba, and Allium fistulosum. According to the present invention, the extracts of twenty nine medicine plants contain a large amount of phenolic compounds, have high ability to remove DPPH radicals and ABTS radicals, and exhibit excellent activity to inhibit xanthine oxidase, and thus are useful for prevention, improvement, or treatment of gout. Further, the extracts of the present invention have edible medicine plants as raw material, and thus have few side effects. Especially, the compositions can be very easily taken when being prepared in a type of functional food or food additive, and thus the compositions of the present invention are expected to be very effective.

Description

29가지 약재 추출물을 유효성분으로 함유하는 통풍 예방, 개선 또는 치료용 조성물{Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient}Compositions for preventing, improving or treating gout, containing 29 medicinal extracts as active ingredients {compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient}

본 발명은 29가지 약재 추출물을 유효성분으로 함유하는 통풍 예방, 개선 또는 치료용 조성물에 관한 것으로, 구체적으로 황금, 금은화, 목천료, 몰약, 희렴, 목과, 백지, 형개, 지실, 해동피, 포공영, 위령선, 죽여, 현호색, 홍화, 천궁, 우슬, 창출, 진피, 백출, 연교, 건지황, 백복령, 감초, 길경, 독활, 의이인, 백개자 및 총백의 수추출물을 유효성분으로 함유하는 통풍 예방, 개선 또는 치료용 조성물에 관한 것이다.
The present invention relates to a composition for preventing, improving or treating gout containing 29 medicinal herb extracts as an active ingredient, specifically, golden, gold, silver, myrrh, myrrh, euphoria, tree, white paper, mold opening, jisil, Haedongpi, pogongyoung, Gastrointestinal tract, kill, Hyunho colors, safflower, celestial organs, dew, creation, dermis, baekrye, yeonkyo, geonjihwang, baekbokyeong, licorice, gilyeong, venom, uiyiin, white ginseng and ginseng extracts as an active ingredient to prevent, improve or treat It relates to a composition for.

통풍이란 퓨린(purine) 대사의 이상(1)으로 혈청 요산 농도가 높아지면서 혈액 내에서 요산염 결정이 관절의 연골, 힘줄 주위 조직에 침착되어 극심한 통증과 발열 및 종창을 일으키는 질병(2)이다. 요산 농도가 7.0㎎/㎗ 이상(여성의 경우에는 6.0㎎/㎗ 이상)이면 고요산혈증으로 정의되며, 고요산혈증 만으로 통풍 증상이 나타나지는 않지만 직적접인 관련성이 있다고 판단한다(3). 여성보다는 주로 남성에게 발생하는데, 이는 남성의 경우 신장에서의 요산 제거 능력이 나이가 들수록 감소하기 때문인 것으로 알려져 있다(4).Gout is an abnormality in purine metabolism (1), which leads to extreme pain, fever, and swelling due to the increase in serum uric acid concentrations and the deposition of urate crystals in the blood in the cartilage of the joints and surrounding tissues. If uric acid concentration is 7.0 mg / dL or higher (6.0 mg / dL in females), it is defined as hyperuricemia, and it is determined that hyperuricemia alone does not produce gout symptoms but is directly related (3). It occurs mainly in men, rather than women, because men's ability to remove uric acid in the kidneys decreases with age (4).

통풍 질환으로 병원에서 치료를 받은 환자들의 통계를 보면 입원 및 외래진료 치료를 받은 환자 중 입원 치료의 경우 2009년에는 5,111명, 2010년에는 5,643명으로 10.4% 증가하였고, 외래 진료 치료를 받은 환자의 경우 2009년에는 222,495명, 2010년에는 240,203명으로 8% 정도 증가하였으며 통풍 환자를 전체적으로 볼 때 2009년에는 227,606명, 2010년도에는 245,846명으로 약 8% 정도 증가한 것으로 나타났다(5 ~ 6).According to the statistics of patients treated in hospital for gout disease, inpatient treatment increased by 10.4% to 5,111 in 2009 and 5,643 in 2010. Cases increased by 8% to 222,495 in 2009 and 240,203 in 2010. The overall gout patients increased by 8% to 227,606 in 2009 and 245,846 in 2010 (5 ~ 6).

통풍 발생 경로를 우리 몸의 장기를 통하여 살펴볼 때, 신장은 우리 몸의 수액대사의 근원으로서 각종 스트레스, 과다한 음주, 약물의 과다 복용 등 여러 가지의 원인으로 인해 신장의 기능이 저하되면 우리 몸의 정기(精氣)가 약해져 몸을 지탱해 주는 기(氣)가 뭉쳐지고, 담(痰)과 어혈(瘀血)이 발생하고 혈액 내에 축적되어 이로 인해 요산배설기능장애가 발생되고 고요산혈증으로 통풍이 발생한다고 볼 수 있다. 일반적으로 통풍 환자들은 일반인에 비해 신장 질환이 20 ~ 60% 더 많이 발생하는 것으로 알려져 있다(7).When examining gout paths through the organs of the body, the kidneys are the source of fluid metabolism in the body. When the kidneys are deteriorated due to various causes such as stress, excessive drinking, and overdose of drugs, (精 氣) is weakened to support the body (氣) is united, phlegm and fish blood (瘀血) is generated and accumulate in the blood, which causes uric acid excretion dysfunction, and hyperuricemia causes gout It can be said that. In general, gout patients are known to have 20 to 60% more kidney disease than the general population (7).

통풍은 급성통풍과 만성통풍으로 구분 지을 수 있으며, 급성통풍은 처음부터 가벼운 증상에서 시작하여 대개 양쪽 엄지발가락에 열을 동반한 극심한 통증과 부어오르는 증상이 나타나는데 야간에 더욱 심하며(8 ~ 11), 음주, 과격한 운동, 탈수, 수술, 출혈, 외상, 요산 배출에 영향을 미치는 과다한 약물 복용 등 여러 요인으로 인하여 완화와 재발하는 과정을 반복하다 보면 하얗게 치약같은 결절이 발생되는 만성결절성통풍, 통풍성신병증으로 진행되어 관절의 기능을 잃고 심지어는 기형이 발생하기도 한다(12).Gout can be divided into acute and chronic gout, which starts with mild symptoms from the beginning and usually causes severe pain and swelling with heat on both toes (8-11). Chronic nodular gout and gouty nephropathy, which can lead to white toothpaste-like nodules due to various factors such as drinking, intense exercise, dehydration, surgery, bleeding, trauma, and excessive drug use affecting uric acid discharge As a result, the joints lose their function and even malformations occur (12).

극심한 통증을 동반하는 통풍 환자들에게 사용되는 대표적인 약물인 콜히친, 비스테로이드항염제, 스테로이드 등 약물에 의한 부작용으로 인해 대사증후군과 신장병 등 합병증으로 고생하고 수명이 단축될 수 있다는 보고가 나오고 있다(13). 이에 안전하면서도 정확한 치료약을 개발 중에 있으나 아직까지는 별다른 성과가 없는 실정이다.It has been reported that side effects caused by drugs such as colchicine, nonsteroidal anti-inflammatory drugs, and steroids, which are used for gout patients with severe pain, may suffer from complications such as metabolic syndrome and kidney disease and shorten their lifespan (13). . Therefore, while developing safe and accurate medicines, there are no results.

최근 식생활의 변화 중에서 서구화에 따른 육류 소비량의 증가와 비만 인구의 증가, 운동 부족 그리고 우리나라 고유의 각종 회식 문화에 기인한 음주 문화가 통풍을 일으키는 주요 원인이 되고 있고 있다. 예방으로는 적절한 약물과 식이요법이 가장 중요하며 적절한 운동요법, 체중조절, 금주 등 절제된 생활이 필요함은 주지의 사실이다.In recent years, the increase in meat consumption, obesity increase, lack of exercise, and drinking culture caused by various Korean drinking cultures have become the main causes of gout. It is well known that proper medication and diet are the most important for prevention, and that moderate exercise such as proper exercise, weight control, and abstinence are necessary.

통풍에 효과가 있다고 알려진 약초 중에서 일부가 통풍에 대한 치료와 예방에 효과가 있을 것으로 사료되는 연구 결과가 발표된 것은 있다(14 ~ 16).Some herbs are known to be effective against gout, and some studies have suggested that some of them may be effective in treating and preventing gout (14–16).

하지만, 한 가지 약초로 통풍을 치료하기에는 우리 인체의 내부 기전 상 상당히 어려워 보이며 아직까지 통풍의 극심한 통증을 유발시키는 고요산의 발생을 억제하고 신장 기능을 정상으로 회복시켜 줌으로써 통풍 치료 및 개선이 되는 의약품 또는 식품 개발은 아직도 더딘 상태이다.
However, it is very difficult to treat gout with one herb, and it is still difficult to treat and improve gout by suppressing the generation of hyperuric acid that causes severe pain of gout and restoring kidney function to normal. Or food development is still slow.

이에 본 발명자는 통풍에 효과적이며 부작용이 적은 약제를 개발하고자 하였으며, 또한 이를 일상생활에서 쉽게 섭취할 수 있는 식품의 형태로도 적용할 수 있도록 하기 위하여 예의 연구 노력하였다.Accordingly, the present inventors have attempted to develop a medicine that is effective in gout and has fewer side effects, and also made an intensive research effort to be able to apply it in the form of food which can be easily consumed in daily life.

우선 부작용 문제를 고려하여 한약재나 식용으로 사용되는 약초를 대상으로 연구하였고, 이러한 약초들 중에서 통풍 증세의 극심한 통증을 없애고 뭉쳐진 기와 담, 어혈을 파기하고 염증과 독을 없애며 통증 부위의 열을 내리고 소변 등 배설 기능을 원활하게 하여 전체 경락을 통하게 할 수 있는 약초들을 선별 및 조합한 다음 다양한 실험을 통해 통풍에 대한 효과를 검증하였다.First of all, we studied herbal medicines and edible herbs in consideration of side effects, and among these herbs, we eliminated the extreme pain of gout symptoms, destroyed the clumps, phlegm, and blood, eliminated inflammation and poisoning, and lowered the heat in the pain area and urine. Herbs that were able to make the whole meridians smooth through the excretion function were selected and combined, and the effects on gout were verified through various experiments.

이의 결과, 29가지의 식용 약초 추출물이 통풍에 대한 예방, 지연, 개선 또는 치료 효과가 우수하며, 식용 약초를 원료로 하기 때문에 부작용이 적고 식품 등으로 용이하게 적용할 수 있어 일상생활에 지장을 주지 않고 장기간 쉽게 복용할 수 있음을 확인하고 본 발명을 완성하게 되었다.
As a result, 29 kinds of edible herb extracts are excellent in preventing, delaying, improving or treating gout, and because they use edible herbs as raw materials, they have less side effects and can be easily applied to foods. After confirming that it can be easily taken for a long time without completing the present invention.

1. 이귀녕, 이종순 : 임상병리파일, 서울, 의학문화사, pp. 86-88, 92-98, 683-685, 732, 733, 749-745, 752, 755, 756, 1404-1406, 1993.Lee, Gwi-Nyung and Jong-Soon Lee: Clinical Pathology, Seoul, Korea. 86-88, 92-98, 683-685, 732, 733, 749-745, 752, 755, 756, 1404-1406, 1993. 2. Lee YH. Diagnosis and management of gout. 2002. J Korean Acad Fam Med 23: pp. 261-266.2. Lee YH. Diagnosis and management of gout. 2002. J Korean Acad Fam Med 23: pp. 261-266. 3. Janson RW. 2002. Gout. In Rheumatology Secrets: West S, ed. Hanley & Belfus Inc., Philadelphia, USA. pp. 325-333.3. Janson RW. 2002. Gout. In Rheumatology Secrets: West S, ed. Hanley & Belfus Inc., Philadelphia, USA. pp. 325-333. 4. Health Insurance Review & Assessment Service. 2011. 2010 National Health Insurance Statistical Yearbook. pp. 559-578.4. Health Insurance Review & Assessment Service. 2011. National Health Insurance Statistical Yearbook. pp. 559-578. 5. 2010년 건강보험통계연보(2011년 12월) 통계청 승인 제920-06호 ISSN 1738-8945 질병소분류별 입원다빈도(외래다빈도) 상병급여현황 pp. 559-578.5. 2010 Annual Health Insurance Statistics Annual Report (December 2011) Korea National Statistical Office No. 920-06 ISSN 1738-8945 Status of hospitalization by hospital subclasses 559-578. 6. 2011년 건강보험통계연보(2012년 12월) 통계청 승인 제92006호 ISSN 1738-8945 질병소분류별 입원다빈도(외래다빈도) 상병급여현황 pp. 624-641.6. 2011 Annual Report of Health Insurance Statistics (December 2012) Approved by National Statistical Office No. 92006 ISSN 1738-8945 Status of hospitalization by hospital subclasses 624-641. 7. Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther 2008; 324: pp. 1-7.Kutzing MK, Firestein BL. Altered uric acid levels and disease states. J Pharmacol Exp Ther 2008; 324: pp. 1-7. 8. Domonks, A. N., Arnold, H. L & Odom, R. B. : Errors of Metabolism, Diseases of the skin, 7th Ed., W.B. Saunders, pp. 684-685, 1982.Domonks, A. N., Arnold, H. L & Odom, R. B .: Errors of Metabolism, Diseases of the skin, 7th Ed., W.B. Saunders, pp. 684-685, 1982. 9. Wyngaarden, J. B. : Gout in Textbook of Medicine Wyngaarden, J. B., L. H. , 16TH eD., W. B. Saunders, pp. 1107-1118, 1982.9. Wyngaarden, J. B .: Gout in Textbook of Medicine Wyngaarden, J. B., L. H., 16TH eD., W. B. Saunders, pp. 1107-1118, 1982. 10. 李文鎬 外 : 內科學, 서울, 금강출판사, pp. 2304-2317.10. 李 文 李 外: Journal of the Institute, Seoul, Geumgang Publishing Co., pp. 2304-2317. 11. 대한피부과학회 : 피부과학, 서울, 어문각, pp. 417-418.11. Korean Dermatological Association: Dermatology, Seoul, Eommungak, pp. 417-418. 12. 대한류마티스학회지(조소영, 박용범, 이찬희) Vol. 18, No. 1, March, 2011, p. 26.12. The Korean Journal of Rheumatology (So-Young Cho, Yong-Bum Park, Chan-Hee Lee) Vol. 18, No. 1, March, 2011, p. 26. 13. 대한류마티스학회지 Vol. 18, No. 4. : Rising Gout, Life Threatening Public Enemy, 송정수, 2011, pp. 234-238.13. The Korean Journal of Rheumatology Vol. 18, No. 4. Rising Gout, Life Threatening Public Enemy, Jung Soo Song, 2011, pp. 234-238. 14. 대전대학교 한의학연구소 논문집 : The Effect of Yindong on Gout of Rats induced by Monosodium Urate, Vol. 17, No. 1, pp. 83-92, 2008.14. The Institute of Oriental Medicine, Daejeon University: The Effect of Yindong on Gout of Rats induced by Monosodium Urate, Vol. 17, No. 1, pp. 83-92, 2008. 15. 대전대학교 한의학연구소 논문집 : The Effect of Smilacis Glabrae Rhizoma on Rsts with Gout induced by Monosodium Urate, Vol. 17, No. 1, pp. 95-103, 2008.15. The Research Institute of Oriental Medicine, Daejeon University.The Effect of Smilacis Glabrae Rhizoma on Rsts with Gout induced by Monosodium Urate, Vol. 17, No. 1, pp. 95-103, 2008. 16. Kang, M. G., Bolormaa, Zanabaatar., Lee, J. S., Sea, G. S., Lee, J. S., Antithy pertensive Activity and Anti-gout Activity of Mushroom Sarcodon aspratus, Kor. j. Mycol. 39(1) : pp. 53-56(2011).16 Kang, M. G., Bolormaa, Zanabaatar., Lee, J. S., Sea, G. S., Lee, J. S., Antithy pertensive Activity and Anti-gout Activity of Mushroom Sarcodon aspratus, Kor. j. Mycol. 39 (1): pp. 53-56 (2011).

따라서 본 발명의 주된 목적은 통풍에 대한 예방, 지연, 개선 또는 치료 효과가 우수하며 부작용이 적은 약제학적 조성물, 기능식품 또는 식품첨가물을 제공하는데 있다.
Therefore, the main object of the present invention is to provide a pharmaceutical composition, nutraceutical or food additive with excellent side effects of preventing, delaying, improving or treating gout and having fewer side effects.

본 발명의 한 양태에 따르면, 본 발명은 황금, 금은화, 목천료, 몰약, 희렴, 목과, 백지, 형개, 지실, 해동피, 포공영, 위령선, 죽여, 현호색, 홍화, 천궁, 우슬, 창출, 진피, 백출, 연교, 건지황, 백복령, 감초, 길경, 독활, 의이인, 백개자 및 총백의 수추출물을 유효성분으로 함유하는 통풍 예방 또는 치료용 약제학적 조성물을 제공한다.According to an aspect of the present invention, the present invention is golden, gold, silver, myrrh, myrrh, bliss, neck, white paper, mold opening, fruiting, haedongpi, pogongyeong, lieutenant line, kill, hyundai, safflower, celestial arch, dew, creation, dermis, Provided is a pharmaceutical composition for preventing or treating gout containing water extracts of Baekchul, Yeongyo, Guernsey, Baekbokyeong, Licorice, Gilgyeong, Dokyeong, Uiin, Baekja and Chongbaek as active ingredients.

본 발명의 다른 양태에 따르면, 본 발명은 상기 수추출물을 유효성분으로 함유하는 통풍 예방 또는 개선용 기능식품을 제공한다.According to another aspect of the present invention, the present invention provides a functional food for preventing or improving gout containing the water extract as an active ingredient.

본 발명의 또 다른 양태에 따르면, 본 발명은 상기 수추출물을 유효성분으로 함유하는 통풍 예방 또는 개선용 식품첨가물을 제공한다.
According to another aspect of the present invention, the present invention provides a food additive for preventing or improving gout containing the water extract as an active ingredient.

본 발명은 특정 용도로 사용하거나 특정 증상에 대한 효과가 있는 것으로 알려진 다양한 한약재를 바탕으로 하여, 본 발명자가 통풍의 예방, 개선 또는 치료 효과를 위해 필요할 것이라 판단되는 약재를 선별 및 조합하고, 실험을 통해 증명함으로써 완성된 것이다.The present invention is based on a variety of herbal medicines known to be used for a specific purpose or effective for a particular symptom, and the present inventors select and combine the medicines determined to be necessary for the prevention, improvement or treatment effect of gout, It is completed through proof.

통풍에 관한 기존 연구결과에 따라 본 발명자는 ① 요산덩어리의 염증을 파괴시키고 ② 발열과 통증을 없애고 ③ 경락을 소통시킴으로써 ④ 어혈을 제거하고 ⑤ 소변 등 배설기능을 원활하게 하여 ⑥ 기운을 보하면서 신장기능이 정상으로 회복될 수 있도록 한다면 통풍을 예방 및 치료할 수 있을 것으로 판단하였으며, 이에 따라 상기와 같은 약재 조합을 결정하였다. 각 약재의 비율 또한 필요 작용효과를 고려하여 결정하였다.According to the existing research results on gout, the present inventors ① destroy the inflammation of uric acid, ② eliminate fever and pain, ③ communicate with meridians, ④ remove fish blood, ⑤ smooth the excretion function such as urine, and ⑥ watch the kidneys. It was determined that gout can be prevented and treated as long as the function can be restored to normal, and thus, the combination of medicines was determined. The ratio of each medicine was also determined in consideration of the necessary effects.

황금, 금은화, 포공영, 연교 및 죽여는 청혈해독(淸熱解毒)을 위해, 목천료, 몰약, 백지, 현호색, 백개자 및 위령선은 지통(止痛)을 위해, 희렴, 목과 및 해동피는 통경락(通經絡)을 위해, 홍화, 천궁, 길경 및 우슬은 활혈거어(活血祛瘀)를 위해, 형개, 건지황, 독활 및 총백은 해표(海表)를 위해, 지실은 파기(破氣)를 위해, 창출, 백출 및 감초는 보기(補氣)를 위해, 진피는 이기(理氣)를 위해, 백복령 및 의이인은 이수(利水)를 위해 구성하였다.Mokcheonryo, Myrrh, White Paper, Hyunho Color, Baekjaja, and Maengnseon for Jitong, Hyeomyeong, Thirsty and Thawing Blood For safflower, saenggung, cheongung, gilgyeong, and hyssop for live bloodfish, hyeonggae, geonjihwang, venom and baekbaek for haemul, for the digging, Creation, harvest and licorice are organized for the sake of view, dermis for selfishness, and Baekbokryeong and Uiin for the sake of water.

본 발명에서는 29가지의 약재를 사용하는데, 각 약재에 대해 대한약전에 수록된 것을 기준으로 하여 다음과 같이 정의한다.In the present invention, 29 kinds of medicines are used, which are defined as follows on the basis of those listed in the Pharmacopoeia for each medicine.

황금(黃芩)은 꿀풀과에 속한 썩은풀의 주피를 벗긴 뿌리로, 청열조습(淸熱燥濕), 사화해독(瀉火解毒) 약리작용이 있어 급성염증의 해독 및 발열에 사용하며, 주성분 baicalein에 의해 항균 및 진균에 대한 억제작용 및 현저한 이뇨작용이 있어 청열의 방제에 유효하다.Golden (黄 芩) is the root of the decayed grass belonging to the Lamiaceae and has the pharmacological action of blue-heat damping and dehydration detoxification. It is used for the detoxification and fever of acute inflammation. By antibacterial and fungal inhibitory effect and remarkable diuretic effect is effective in the control of clear heat.

금은화(金銀花)는 인동과에 속한 인동덩굴의 꽃봉오리로, inositol, luteolin, tannin 등을 주성분으로 하는 청열해독(淸熱解毒) 약리작용이 있어 백선균에 대한 억제작용 및 황색포도구균 등에 강한 광 spectrum 항균약제로서 influenza virus를 억제하는 효능이 있으며 화농성피부질환에 대한 상용약으로 고름, 부스럼 등으로 발적, 열감동통이 있을 때 반드시 사용한다.Geumeunhwa (金 꽃 花) is a bud of the honeysuckle, which belongs to the genus Phloxaceae. It has a pharmacological action of blue heat detoxification, which mainly contains inositol, luteolin, and tannin. It is a spectrum antimicrobial drug that has the effect of inhibiting influenza virus. It is a commercial drug for purulent skin disease. It must be used when there is redness and heat pain due to pus and swelling.

목천료(木天蓼)는 다래나무과에 속한 다래나무 및 동속근연식물의 벌레먹은 열매로, 악티니딘, 마타타페락톤, β-페닐에텔알코올 성분은 미주신경중추에 작용함으로써 염증을 삭이고 몸 안에 있는 요산을 밖으로 내보냄으로써 통증을 억제하는 효과가 탁월하여 진통약으로 사용하며 손발의 마비를 치료하며 혈액순환이 잘되게 하는 작용이 있다.Mokcheonryum is a insect-infested fruit of the perennial plant and the related plant of the genus Tetaceae. Actinidine, Matataferlactone, and β-phenylethel alcohol are acted on the vagus nerve center to relieve inflammation. By sending out the uric acid, the effect of suppressing pain is excellent, it is used as an analgesic medicine, it treats numbness of the hands and feet, and works to improve blood circulation.

몰약(沒藥)은 감람나무과에 속한 몰약나무 또는 동속식물에서 얻은 고무수지로, 유지, 정유, 수교(樹膠) 등을 주성분으로 하는 활혈거어지통(活血祛瘀止痛)의 약리작용으로 수렴작용과 담을 없애는 작용 및 많은 종류의 진균(眞菌)에 대한 억제작용이 있어 관절의 동통에 사용하면 치료 효과가 크다.Myrrh is a rubber resin obtained from the myrrh tree or the same plant belonging to the olive tree family. The myrrh is converging by the pharmacological action of the livestock stems, which are mainly composed of fats and oils, essential oils and handing. There is a function of removing the phlegm and inhibiting many kinds of fungi, which can be used for joint pain.

희렴은 국화과에 속한 진득찰 및 동속근연식물의 지상부 전초로, darutin, alkaloid 등을 주성분으로 하는 거풍습(祛風濕), 통경락(通經絡) 등의 약리작용 있어 관절염에 대하여 항염증작용이 있다. 주로 풍습으로 인한 팔다리가 저리고 무릎이 차가우면서 통증이 있는데 사용하며 사지마비, 무릎무력증 등의 증상이 수반될 때 적합하다.Happiness is a terrestrial outpost of Jindukchal and cognate root plants belonging to the Asteraceae family. It is mainly used when the limbs are cold due to the customs, the knee is cold, and the pain is used, and it is suitable when there are symptoms such as quadriplegia and knee weakness.

목과(木瓜)는 장미과에 속한 모과나무의 잘 익은 열매로, saponin, malic acid, 주석산, limonic acid, 비타민C, 탄닌 등을 주성분으로 하는 서근활락(舒筋活絡) 등 통경락(通經絡)의 약리작용이 있어 풍습으로 인한 하지근무력, 요슬운동마비, 관절염 등 경련을 천천히 풀어주는 작용이 있다.The tree is a ripe fruit of the Chinese quince tree belonging to the Rosaceae family, and the roots of Tong Kyung-rak, such as Sugeun lak, whose main components are saponin, malic acid, tartaric acid, limonic acid, vitamin C, and tannin. It has a pharmacological action, which slows down cramps such as muscle strength of the lower limbs due to the customs, muscle movement paralysis and arthritis.

백지(白芷)는 미나리과에 속한 다년생초본인 구릿대 또는 그 변종의 뿌리로, angellicin, angelicol, angelicotoxin 등을 주성분으로 하는 거풍해표(祛風解表), 소종배농(消腫排膿) 등의 약리작용이 있어 진통작용 약제로 사용하는데 통증을 완화시키는데 보조약으로 사용한다.Baekji (白芷) is the root of perennial herbaceous guridae or its varieties belonging to the Araaceae family, and has pharmacological effects such as Geophae Haeum (소 風 解 表) and small bell pepper (으로), mainly composed of angellicin, angelicol, and angelicotoxin. It is used as an analgesic drug to relieve pain.

형개(荊芥)는 꿀풀과에 속한 형개의 꽃필 때 꽃대로, l-mentol, dl-mentol 과 소량의 d-limonene를 포함하고 있는 정유를 주성분으로 하는 거풍해표(祛風解表) 등의 약리작용이 있다. 해열작용이 있으며 피부의 혈행을 왕성하게 하며 땀샘의 분비를 촉진시켜 경련을 해소하는데 그 작용이 있으며 피부의 병변조직의 파괴흡수를 촉진하고 가려움증을 없애는 작용이 있다.Hungae is a pharmacological action of the sperm of the hwalyeom belonging to the Lamiaceae, in the form of a flower, a giant wind haejugo (祛風 解 表) consisting mainly of essential oils containing l-mentol, dl-mentol and a small amount of d-limonene There is this. It has an antipyretic effect and makes the blood circulation of the skin vigorous and promotes the secretion of sweat glands to relieve spasms. It has the effect of promoting destruction and absorption of lesion tissue of the skin and eliminating itching.

지실(枳實)은 산초과에 속한 탱자나무의 익지 않은 열매를 그대로 또는 반으로 자른 것으로, limonene 등으로 된 정유, hesperidin, aurantiamarin 등의 flavon류 등을 주성분으로 하는 행기소적(行氣消積) 등의 약리작용으로 위장의 유동을 증강시키고 유동 리듬을 조정하고 긴장도를 높인다.Fruits are cut in half or in unripe fruits of tanza, which belongs to the mountain family, and are traces of essential oils consisting of limonene, essential oils, and flavons such as hesperidin and aurantiamarin. The pharmacological action of the back enhances the flow of the stomach, adjusts the flow rhythm and increases the tension.

해동피(海桐皮)는 콩과에 속한 엄나무의 껍질로, 해동피 alkaloid 등을 주성분으로 하는 거풍통락(祛風通絡)의 약리작용이 있어 만성관절 류마티즘에 좋고 풍습으로 인한 무릎, 하지 동통에 특히 좋다. 피부진균증에 사용하며 타박상, 골절상 등으로 인한 관절의 통증, 운동장해 등에 사용하면 지통과 운동회복에 효과가 있다.Haedongpi (海桐 皮) is a bark of the oak tree belonging to the legumes, and has the pharmacological action of Geopungtongrak (하는 風 通 絡), which mainly contains alkaloid, etc., which is good for chronic joint rheumatism and especially for knee and leg pain caused by custom. good. It is used for skin fungus, and it is effective for pain and exercise recovery when it is used for joint pain, exercise disorder due to bruises, fractures, etc.

포공영(蒲公英)은 국화과에 속한 민들레 및 동속식물의 전초로, 결정성고미질(結晶性高味質)인 taraxacin, traraxarol, asparagin 등을 주성분으로 하는 청열해독(淸熱解毒) 약리작용이 있어 피부진균을 억제함으로써 급성 염증에 사용하고, 아미노기 전이반응을 통해 생성되는 아미노기는 요산으로 전환됨으로써 체내에서 방출되도록 하는 transaminase(아미노기 전이효소) 수치가 높을 경우 transaminase 수치를 떨어뜨리는 역할을 함으로써 요산에 의해 야기되는 질병에 응용하며 일반적인 소염해독제로 쓰인다.Pogong-young is an outpost of dandelion and the same plant belonging to the Asteraceae family, and has fungal detoxification pharmacological action mainly composed of crystalline high quality taraxacin, traraxarol and asparagin. It is used for acute inflammation by inhibiting the amino acid, and the amino group produced through the amino group transfer reaction is converted to uric acid and the transaminase level is high. It is applied to diseases and used as a general anti-inflammatory agent.

위령선(威靈仙)은 미나리아재비과에 속한 으아리 및 동속근연식물의 뿌리로, anemonin, anemol 등을 주성분으로 하는 지통(止痛)의 약리작용이 강하여 사지관절통, 관절의 운동장해, 수족마비 등의 증상을 수반하는 만성관절 류마티즘에 사용한다.Euiyeongseon (威靈仙) is a root of the Eurasian colostrum plant belonging to the genus Minaria, and has a strong pharmacological effect of lichen pain, which is composed mainly of anemonin and anemol, etc. It is used for chronic joint rheumatism.

죽여(竹茹)는 벼과에 속한 솜대 또는 왕대의 겉껍질을 제거한 중간층으로, 청열(淸熱), 화담(化痰) 등의 약리작용이 있어 주로 급성 열로 인한 보조약으로 사용한다.Killed (竹茹) is the middle layer removed from the outer shell of the paddle or royal family belonging to the family of rice family, has a pharmacological action, such as blue fever (화), hwadam (化痰) is mainly used as a supplement due to acute fever.

현호색(玄胡索)은 양귀비과에 속한 들현호색과 또는 그 밖의 동속식물의 덩이줄기로, 15종의 alkaloid를 주성분으로 하는 지통(止痛) 및 최면의 약리작용이 있어 우리 몸의 모든 통증을 치료하는데 사용하며 특히 관절통, 타박손상통 등의 기체어혈로 인한 무딘 통증에 응용하면 확실한 진통효과가 있다.Hyunho-saeng (玄 胡 索) is a tuber of wild hyacinth or other similar plants belonging to the poppy family. It has 15 kinds of alkaloid-based pain and hypnotic pharmacological action to treat all the pain in our body. In particular, when applied to blunt pain caused by gaseous blood, such as joint pain, bruise injury pain, there is a certain analgesic effect.

홍화(紅花)는 국화과에 속한 잇꽃의 관상화를 그대로 또는 황색색소의 대부분을 제거하고 압착하여 판상으로 한 것으로, carthamin, saflor yellow 등을 주성분으로 하는 파어활혈(破瘀活血), 통경(通經) 약리작용이 있어 어혈월경통, 무월경에 대하여 홍화의 자궁흥분과 활혈통경의 효능을 이용하고 타박염좌에 의한 내출혈, 통증에 사용한다.Safflower is a plate made of the corolla of safflower belonging to the chrysanthemum as it is or by removing most of the yellow pigment and pressing it. ) It has pharmacological effects on the erythematous dysmenorrhea and amenorrhea. It is used for safflower uterus excitement and synovial liner.

천궁(川芎)은 미나리과에 속한 천궁의 뿌리줄기를 그대로 또는 열탕에 데친 것으로, alkaloid, ferulic acid, 정유, 일종의 結晶性中性物質 등을 주성분으로 하는 활혈행기(活血行氣), 거풍지통(祛風止痛) 약리작용이 있다. 정유는 중추신경계에 작용하여 대뇌의 활동을 억제한다. 카페인의 흥분작용을 억제시키는 작용이 있다. 각종 피부진균을 억제하며, 근육에 대한 근류마티즘, 만성관절 류마티즘 등에 사용한다.Cheongung is a boiled boiled boiled as it is, or boiled in boiling water. It is an active blood locomotive, an active form of blood, which contains alkaloids, ferulic acid, essential oils, and some sort of 結晶 性 中性 物.祛風 止痛) pharmacological action. Essential oils act on the central nervous system to inhibit the activity of the cerebrum. Caffeine has the effect of suppressing the excitement. It inhibits various skin fungi and is used for muscle rheumatism and chronic joint rheumatism.

우슬(牛膝)은 비름과에 속한 쇠무릎의 뿌리로, 사포닌, 다량의 칼륨염, 알칼로이드를 주성분으로 하는 거어지통(祛瘀止痛), 활혈통경(活血通經) 등의 약리작용이 있다. 진통작용 및 이뇨작용이 있어 신허, 풍습, 타박염좌 등의 원인을 불문하고 요퇴통에는 우슬을 사용하고 풍습으로 인한 요퇴통, 비통(痺痛), 요통, 사지동통에 사용한다.Root (牛膝) is the root of the iron knee belonging to the amaranth family, and it has pharmacological action such as saponin, a large amount of potassium salt, alkaloid-based beetle pain, and active blood circulation. . There is analgesic and diuretic effect, regardless of the cause of the license, customs, bruises sprains, etc. The lumbar pain is used for the lumbar pain, lumbar pain caused by the customs, pain, limb pain, limb pain.

창출(蒼朮)은 국화과에 속한 가는 잎 삽주 또는 만주삽주의 뿌리줄기로, atractylol, atractylon 등을 함유한 정유, 비타민D 등을 주성분으로 하는 조습건비(燥濕健脾) 등의 약리작용이 있어 위장을 튼튼하게 하는 강장작용 및 진정작용이 있다. 몸속의 풍(風)을 없애는 중요한 약물이며 내습(內濕), 외습(外濕)에 다 사용해도 좋으나 외습에는 창출이 가장 유효하다. 强壯작용이 있으므로 온몸에 힘이 없거나 움직이기 싫을 때 사용한다.Creation (蒼朮) is the root stem of fine leaf or Manchurian inserts belonging to the Asteraceae family, and it has pharmacological action such as essential oils containing atractylol, atractylon, etc. There is a tonic and sedative to tonic. It is an important drug to get rid of wind in the body. It can be used for both invasion and invasion, but creation is most effective for invasion. This action is used because when there is no strength in the whole body or you do not want to move.

진피(陣皮)는 산초과에 속한 귤 또는 동속 근연식물의 성숙한 과피로, hesperidin, myoinoisitol, d-limonene, 비타민B1 등을 주성분으로 하는 이기건비(理氣健肥) 등의 약리작용이 있어 위를 튼튼하게 하므로 소화불량증에 사용하고 구역질을 멈추게 하며 몸속의 가래를 없애고 기도를 확장시키므로 호흡이 편안해진다.Dermis is a mature skin of tangerine or related plant of the same family, which has a pharmacological effect such as hegiidin, myoinoisitol, d-limonene, and vitamin B1. Because it is strong, it is used for dyspepsia, stops nausea, eliminates phlegm in the body, and expands the airways, making breathing comfortable.

백출(白朮)은 국화과에 속한 삽주의 주피를 제거한 뿌리줄기로, atractylol 를 주로 하는 精油, atractylol, 비타민A 등을 주성분으로 하는 보비익기(補脾益氣) 등의 약리작용이 있어 소화를 돕고 이뇨작용이 현저하고 지속성이 있어 뇨세관의 재흡수를 억제하고 kalium의 배설을 증가시킨다.Baekchul (白 朮) is a rhizome that removes the cuticle of the inflorescence belonging to the chrysanthemum family, and it has pharmacological action such as 精油, which mainly contains atractylol, atractylol, and vitamin A. Its remarkable and persistent action inhibits the resorption of urine tubules and increases the excretion of kalium.

연교(連翹)는 물푸레나무과에 속한 의성개나리, 개나리 또는 중국 개나리의 열매로, forsythol, oleanic acid 등을 주성분으로 하는 청열해독(淸熱解毒) 약리작용이 있어 황색포도구균, 적리균A균에 대한 항균력이 가장 강하고 인플루엔자 바이러스를 억제한다. 이뇨작용이 있어 화농성질한으로 발열등 염증 증상이 있을 때 사용한다.Yeon-kyo is the fruit of the forbidden forsythia, forsythia or chinese forsythia, belonging to the ash family, and has the antibacterial activity against the Staphylococcus aureus and S. aureus bacillus because it has a clear heat detoxification effect mainly composed of forsythol and oleanic acid. This is the strongest and suppresses the influenza virus. It has a diuretic effect and is purulent and is used when there are inflammatory symptoms such as fever.

건지황(乾地黃)은 현삼과의 지황의 뿌리 또는 그 밖의 동속식물의 뿌리를 건조한 것으로, rehmanin, xylitol, glucose, mannitol, 철분, 비타민A류 등을 주성분으로 하는 청열양혈(淸熱養血), 양음생진(養陰生津)의 약리작용이 있다. 추출액은 혈액응고를 촉진하고 쇄약한 심장에 대한 강심작용이 현저하며 특히 심장근육에 작용하여 해열을 보조하며 구갈, 변비 등의 탈수증상이 있는 열성질환에 사용한다.Guernsey (乾 地 黃) is a dried root of the sulfur or other related plants of Hyunsam and is a blue-green blood blood (淸 熱 養血) mainly composed of rehmanin, xylitol, glucose, mannitol, iron, vitamin A, etc. , Yang Yin Saengjin (養陰 生 津) has the pharmacological action. Extracts promote blood coagulation and have a strong cardiac effect on the weakened heart. In particular, the extract acts on the heart muscle to aid fever and is used for recessive diseases with dehydration such as dry mouth and constipation.

백복령(白茯笭)는 구멍쟁이버섯과에 속한 복령균의 바같층을 거의 제거한 균핵으로, β-pachymose, pachymic acid, 단백질, 지방, lecitin, histidine, 칼륨염 등을 주성분으로 하는 이수삼습(利水渗濕), 건비화중(健脾和中) 등의 약리작용이 있어 식욕부진, 소화불량, 설사 등 비위허약으로 인한 증세에 사용하며 滋養작용과 鎭靜작용이 있으며 이뇨작용이 있어 수종일 경우에 사용한다. Na, K, Cl 등의 배출을 증가시키고, 뇨세관의 재흡수를 억제한다.Baekbokryeong (白 茯 笭) is a bacterium that almost eliminates the bark of the Baeryeong fungi belonging to the fungi family, and is composed of β-pachymose, pachymic acid, protein, fat, lecitin, histidine, and potassium salt. ), Dry nausea (健脾 和 中) has pharmacological effects such as anorexia, indigestion, diarrhea, etc. It is used for symptoms caused by nasal weakness. Used for Increases the release of Na, K, Cl, etc., and suppresses the resorption of urine tubules.

감초(甘草)는 콩과에 속한 유럽감초, 만주감초 및 동속식물의 뿌리와 주출경을 그대로 또는 주피를 제거한 것으로, liquiritigenin, glucose, mannitol, malic acid, l-asparagine 등을 주성분으로 하는 보기(補氣), 해독(解毒) 등의 약리작용이 있다. 해독의 주약이며 완화, 보익조정의 주약으로 비위를 보하여 기운을 돋우는 데에는 감초를 사용한다. 몸속의 수분과 Na를 저장하고 혈압을 증강시키고 K 배출을 증가시키는 등의 corticoid상 작용을 갖추고 있다.Licorice (甘草) is the root and gourds of European licorice, Manchurian licorice, and the same plants of legumes, as it is, or removed the bark, and contains liquiritigenin, glucose, mannitol, malic acid, and l-asparagine as main ingredients.氣), detoxification (解毒) and the like has a pharmacological action. Licorice is used to invigorate and revitalize the medicine as a medicine for detoxification. It has a corticoid effect such as storing moisture and Na in the body, increasing blood pressure and increasing K release.

길경(桔梗)은 초롱꽃과에 속한 도라지의 뿌리를 그대로 또는 주피를 제거한 것으로, platyciside, inulin, phytosterol 등을 주성분으로 하는 청폐제기(淸肺提氣), 거담배농(祛痰排膿) 등의 약리작용이 있어 기관(氣管)의 분비를 촉진시켜 가래를 없애고 실험관에서 백선균에 대한 억제작용이 있다. 고름을 배출시키고자 할 때 사용하며 감기, 급성기관지염, 폐렴 등 푸안이나 풍열로 인한 감기에 사용한다.Gilkyung is the root of the bellflower belonging to the campanula, or the bark is removed, and the pharmacology of the medicinal plants such as the greening machine (Golda) which is composed mainly of platyciside, inulin, phytosterol, etc. There is a function to promote the secretion of organs (氣管) to eliminate phlegm and to inhibit the ringworm in the test tube. It is used to discharge pus and is used for colds caused by fuan or wind heat such as cold, acute bronchitis and pneumonia.

독활(獨活)은 오갈피나무과에 속한 독활의 뿌리로, 소량의 정유, phytosterol 등을 주성분으로 하는 거풍습(祛風濕), 통경락(通經絡) 등의 약리작용이 있다. 동물 실험에서는 항관절염, 최면작용이 있다. 직접 혈관을 확장해서 혈압을 하강시키고 호흡중추를 흥분시켜 호흡을 증강케 하며 근육이나 하반신 관절의 통증과 마비 등이 있을 때 사용한다.Dokbyeong (獨 活) is the root of the poisonous tree belonging to the ogalpiaceae, has a small amount of essential oils, phytosterol and the pharmacological action, such as gongpungup (祛風濕), Tongkyeongrak (通 經絡). Animal experiments have anti-arthritis and hypnosis. Directly expands blood vessels to lower blood pressure, stimulates the respiratory center to enhance breathing, and is used for pain and numbness in muscles and lower body joints.

의이인(薏苡仁)은 벼과에 속한 율무의 종피를 제거한 씨로, 지방유, coixol, sterol, aminoacid, 비타민 B1 등을 함유하고 있어 풍습으로 인한 근육경련을 감소시키는 등 근육질환에 효과가 있으며, 보조약으로서 이뇨소담(利尿消痰), 거풍지통(祛風止痛), 건비지사(健脾止瀉)에 사용한다.Ui-in (씨 仁) is a seed that removes the seed of Yulmu belonging to the rice family, and contains fatty oil, coixol, sterol, aminoacid, vitamin B1, etc. It is effective for muscle diseases such as reducing muscle spasms caused by customs. Diuretic sodam (利 尿 消痰), Geojeungjik (祛風 止痛), geonbi branch (健脾 止瀉) is used.

백개자(白芥子)는 십자화과에 속한 겨자의 성숙종자로, sinalbin, 지방유, sinalbinase, sinapine 등을 주성분으로 하는 소종지통(消腫止痛)의 약리작용이 있어 동통을 경감시키고 염증 제거를 촉진시키는 효과가 우수하여 근육, 관절의 심한통증에 사용하며 담을 제거하여 염증(炎症)이나 종양(腫瘍) 따위로 말미암아 인체의 국부가 부어있는 증상 등을 소멸시키는데 사용한다.Baekjaja (白芥子) is a mature seed of mustard belonging to Cruciferaceae, and it has the pharmacological action of small sore throat, which contains sinalbin, fatty oil, sinalbinase, sinapine, etc. as a main ingredient to alleviate pain and promote inflammation removal. It is used for severe pain of muscles and joints. It is used to eliminate the symptoms of swollen parts of the human body due to inflammation or tumor by removing phlegm.

총백(蔥白)은 백합과에 속한 파의 신선한 뿌리로, 파기름(蔥油), malic acid, 비타민 B, C, 철염(鐵鹽) 등을 주성분으로 하는 발한해표(發汗解表), 통양(通陽) 등의 약리작용이 있다. 기관지에 가벼운 자극을 주어 가래를 없애고 항균작용이 있어 일반적으로 두통, 코막힘, 땀이 없는 증세 등 발한(發汗)의 보조약으로 사용하고 방광의 기화실조(氣化失調)로 인한 배뇨곤란, 복부팽만, 복통 등에 사용한다.Chongbaek (蔥白) is a fresh root of leeks belonging to the family Liliaceae, sweat persimmon (통 解 表), tongyang (通 發汗) consisting mainly of sesame oil, malic acid, vitamin B, C, iron salts, etc.陽) and pharmacological action. It gives light stimulation to the bronchus, removes phlegm and has antibacterial effect. It is generally used as a supplement for sweating, such as headache, nasal congestion, and sweat-free symptoms. Difficulty in urination due to agitation of bladder and abdomen Used for bloating and abdominal pain.

본 발명에서 수추출물 제조 시 각 약초의 비율은 황금 10 내지 18중량%, 금은화 7 내지 14중량%, 목천료 5 내지 9중량%, 몰약 4 내지 8중량%, 희렴 3 내지 7중량%, 목과 3 내지 7중량%, 백지 3 내지 7중량%, 형개 3 내지 7중량%, 지실 3 내지 7중량%, 해동피 3 내지 6%, 포공영 2 내지 4중량%, 위령선 2 내지 4중량%, 죽여 2 내지 4중량%, 현호색 2 내지 4중량%, 홍화 2 내지 4중량%, 천궁 2 내지 4중량%, 우슬 2 내지 4중량%, 창출 1 내지 3중량%, 진피 1 내지 3중량%, 백출 1 내지 3중량%, 연교 0.5 내지 1중량%, 건지황 0.5 내지 1중량%, 백복령 0.5 내지 1중량%, 감초 0.5 내지 1중량%, 길경 0.5 내지 1중량%, 독활 0.5 내지 1중량%, 의이인 0.5 내지 1중량%, 백개자 0.5 내지 1중량% 및 총백 0.5 내지 1중량%인 것이 바람직하다.In the present invention, the ratio of each herb when preparing the water extract is 10 to 18% by weight of gold, 7 to 14% by weight of silver and silver, 5 to 9% by weight of moths, 4 to 8% by weight, myrrh 3 to 7% by weight, neck and neck 3 To 7% by weight, 3 to 7% by weight of white paper, 3 to 7% by weight, 3 to 7% by weight of fruit fat, 3 to 6% by weight of thawed skin, 2 to 4% by weight of pogongyoung, 2 to 4% by weight of lieutenant stomach, 2-4 to kill % By weight, Corydalis 2-4%, Safflower 2-4%, Cheongung 2-4%, Dew 2-4%, Produce 1-3%, Dermal 1-3%, White 1-1% %, Yeongyo 0.5-1% by weight, 0.5-1% by weight Guernsey, 0.5-1% by weight, Baekbokyeong, 0.5-1% by weight licorice, 0.5-1% by weight, 0.5-1% by weight, Euiin 0.5-1% by weight It is preferable that it is 0.5-1 weight% of a white medium and 0.5-1 weight% of a total bag.

보다 바람직하게는 황금 약 14.09중량%, 금은화 약 10.56중량%, 목천료 약 7.04중량%, 몰약 약 5.63중량%, 희렴 약 4.93중량%, 목과 약 4.93중량%, 백지 약 4.93중량%, 형개 약 4.93중량%, 지실 약 4.93중량%, 해동피 약 4.23중량%, 포공영 약 3.17중량%, 위령선 약 3.17중량%, 죽여 약 3.17중량%, 현호색 약 3.17중량%, 홍화 약 2.82중량%, 천궁 약 2.82중량%, 우슬 약 2.82중량%, 창출 약 2.12중량%, 진피 약 2.12중량%, 백출 약 2.12중량%, 연교 약 0.7중량%, 건지황 약 0.7중량%, 백복령 약 0.7중량%, 감초 약 0.7중량%, 길경 약 0.7중량%, 독활 약 0.7중량%, 의이인 약 0.7중량%, 백개자 약 0.7중량% 및 총백 약 0.7중량%로 하는 것이 좋다.
More preferably, about 14.09% by weight of gold, about 10.56% by weight of gold and silver, about 7.04% by weight of moth, about 5.63% by weight of myrrh, about 4.93% by weight, about 4.93% by weight of neck, about 4.93% by weight of white paper, about 4.93% of mold Weight%, Fruit about 4.93%, Thawing blood about 4.23%, Poongyoung about 3.17%, Maengyeong line about 3.17% by weight, Kill about 3.17% by weight, Corydalis about 3.17% by weight, Safflower about 2.82% by weight, Cheongung about 2.82% by weight About 2.82% by weight, creation about 2.12% by weight, about 2.12% by weight, dermis about 2.12% by weight, about 0.7% by weight of bridge bridge, about 0.7% by weight of dried liquor, about 0.7% by weight of Baekbokyeong, about 0.7% by weight of licorice About 0.7% by weight, about 0.7% by weight of poison, about 0.7% by weight of yiyiin, about 0.7% by weight of white dog, and about 0.7% by weight of total bag.

본 발명의 29가지 약재 수추출물은 의약품, 식품 등의 용도로 사용할 수 있다.The 29 medicinal herb extracts of the present invention can be used for pharmaceuticals, foods, and the like.

이때, 본 발명에 따른 추출물은 식품의약안정청(KFDA)의 통상적인 약제학제 제제로의 제형화 기준 또는 건강보조식품의 제형 기준에 의거하여 제형화할 수 있다.At this time, the extract according to the present invention can be formulated on the basis of the formulation standard of the KFDA (KFDA) as a pharmaceutical formulation or a dietary supplement of dietary supplement.

추출물은 통상적인 방법으로, 투여방법, 투여형태 및 치료목적에 따라 약제학적으로 허용 가능한 담체와 함께 혼합하여 희석하거나, 용기 형태의 담체 내에 봉입시키는 것이 바람직하다.The extract may be diluted in conventional manner, mixed with a pharmaceutically acceptable carrier, or enclosed in a carrier in a container form according to the administration method, dosage form, and therapeutic purpose.

상기 담체가 희석제로 사용되는 경우에는 염수, 완충제, 덱스트로스, 물, 글리세롤, 링거액, 락토즈, 수크로즈, 칼슘 실리케이트, 메틸 셀룰로오즈 및 에탄올로 이루어진 군에서 선택된 적어도 1종 이상의 담체를 사용한 경구투여와 비경구투여용으로 분말, 과립, 주사액, 시럽, 용액제, 정제 등과 같은 제형으로 제조할 수 있다. 다만, 본 발명의 담체가 상기의 담체로 한정되는 것은 아니다. 이때, 비경구 투여는 경구 이외에 직장, 정맥, 복막, 근육, 동맥, 경피, 비강, 흡입 등을 통한 유효성분의 투여를 의미한다.When the carrier is used as a diluent, oral administration with at least one carrier selected from the group consisting of saline, buffer, dextrose, water, glycerol, Ringer's solution, lactose, sucrose, calcium silicate, methyl cellulose and ethanol For parenteral administration it may be prepared in formulations such as powders, granules, injections, syrups, solutions, tablets and the like. However, the carrier of the present invention is not limited to the above carrier. In this case, parenteral administration means administration of the active ingredient through rectal, intravenous, peritoneal, muscular, arterial, transdermal, nasal, inhalation, etc. in addition to orally.

상기 제형에 충진제, 항응집제, 윤활제, 습윤제, 향료, 유화제, 방부제 등을 추가로 포함하여 투여된 후 활성성분의 신속, 지속 또는 지연된 방출을 제공할 수 있도록 제형화 할 수 있다. 그리고 본 발명 추출물의 투여량은 환자의 상태, 투여 경로 및 투여 형태에 따라 조절될 수 있어 한정되지 않으며 증상에 따라 본 발명의 분야에서 통상의 지식을 가진 자라면 자명하게 다양한 범위 내에서 사용할 수 있으나, 통상적으로 본 발명에서는 실험적인 유효량으로 체중 1㎏ 당 2.9 내지 4.3㎖을 하루에 연속적 또는 간헐적으로 투여가 가능할 것으로 판단된다.The formulation may further include fillers, anti-coagulants, lubricants, wetting agents, flavors, emulsifiers, preservatives, and the like, and may be formulated to provide rapid, sustained or delayed release of the active ingredient after administration. And the dosage of the extract of the present invention can be adjusted according to the condition of the patient, the route of administration and the dosage form is not limited and those skilled in the art according to the symptoms can be obviously used within various ranges In general, in the present invention, it is determined that 2.9 to 4.3 ml per kg of body weight can be continuously or intermittently administered per day in an experimental effective amount.

상기 추출물의 유효량을 기준으로, 본 발명은 추출물 그 자체 또는 식품학적으로 허용된 담체를 혼합한 조성물을 포함하는 기능식품 또는 식품첨가물을 제공하는데, 상기 기능식품은 식육가공품, 어육제품, 두부, 묵, 죽, 라면이나 국수 등의 면류, 간장, 된장, 고추장, 혼합장 등의 조미식품, 소스, 과자, 발효유나 치즈 등의 유가공품, 김치나 장아찌 등의 절임식품, 과실, 채소, 두유, 발효음료 등의 음료수의 형태일 수 있으며, 상기 식품첨가물은 이러한 형태의 식품에 첨가하여 사용할 수 있다. 이는 본 발명의 분야에서 통상의 지식을 가진 자라면 자명한 사항으로 이의 구체적인 조리 방법이나 생산 방법의 기재는 생략하기로 한다. 또한 식품학적으로 허용된 담체는 상술한 약제학적으로 허용된 담체도 사용할 수 있다.
On the basis of the effective amount of the extract, the present invention provides a functional food or food additives comprising the composition itself or a mixture of food-acceptable carriers, the functional food is processed meat products, fish meat products, tofu, jelly , Noodles, noodles such as ramen or noodles, seasoned foods such as soy sauce, miso, red pepper paste, mixed soy sauce, dairy products such as sauces, sweets, fermented milk and cheese, pickles such as kimchi and pickles, fruits, vegetables, soy milk, fermented beverages It may be in the form of a beverage, such as, the food additive may be used in addition to this type of food. This is obvious to those skilled in the art of the present invention will not be described the specific cooking method or production method thereof. In addition, the pharmaceutically acceptable carrier may also be used as the pharmaceutically acceptable carrier.

본 발명에 따르면, 본 발명의 29가지 약재 수추출물은 다량의 페놀성 화합물을 함유하고, 높은 DPPH 라디칼 소거능 및 ABTS 라디칼 소거능을 갖으며, 우수한 Xanthine oxidase 저해 활성을 나타내므로, 통풍의 예방, 개선 또는 치료에 유용하게 사용될 수 있다.According to the present invention, the 29 medicinal herb extracts of the present invention contain a large amount of phenolic compounds, have high DPPH radical scavenging ability and ABTS radical scavenging ability, and exhibit excellent Xanthine oxidase inhibitory activity, thereby preventing, improving or preventing gout. It can be usefully used for treatment.

또한, 본 발명의 추출물은 식용 약재를 원료로 하기 때문에 부작용이 적으며, 특히 기능식품이나 식품첨가물의 형태로 제조할 경우 누구나 매우 용이하게 섭취할 수 있어, 더욱 효과적일 것으로 기대된다.
In addition, the extract of the present invention has fewer side effects because it is an edible medicinal raw material, especially when manufactured in the form of functional foods or food additives can be easily taken by anyone, and is expected to be more effective.

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하기로 한다. 이들 실시예는 단지 본 발명을 예시하기 위한 것이므로, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는다.
Hereinafter, the present invention will be described in more detail with reference to Examples. These embodiments are only for illustrating the present invention, and thus the scope of the present invention is not construed as being limited by these embodiments.

< 29가지 약재의 수추출물 제조 ><Preparation of 29 Herbal Extracts>

본 실시예에서 사용한 표 1의 약재를 2012년 8월 ~ 10월경 서울 경동시장에서 구입하였다.The medicines of Table 1 used in this example were purchased at Gyeongdong Market, Seoul, from August to October 2012.

Common nameCommon name Korean nameKorean name Scientific nameScientific name Rehmanniae RadixRehmanniae Radix 건지황(乾地黃)Guernsey Yellow (乾 地 黃) Rehmannia glutinosa Rehmannia glutinosa Angelicae Dahuricae RadixAngelicae Dahuricae Radix 백지(白芷)White paper Angelicae dahurica Angelicae dahurica Araliae Continentalis RadixAraliae Continentalis Radix 독활(獨活)Poisonous activity Aralia continentalis KitagawaAralia continentalis Kitagawa Atractylodes RhizomaAtractylodes Rhizoma 창출(蒼朮)Creation Atractylodes lancea D.CAtractylodes lancea D.C Atractylodes rhizome whiteAtractylodes rhizome white 백출(白朮)Baekchul (白 朮) Atractylodis ovataAtractylodis ovata Scutellariae RadixScutellariae radix 황금(黃芩)Golden Scutellaria baicalensis Gerorgi Scutellaria baicalensis Gerorgi Platycodi RadixPlatycodi Radix 길경(桔梗) Gil-kyung Platycodon grandiflorum NakaiPlatycodon grandiflorum Nakai Bambusae Caulis in TaeniamBambusae caulis in taeniam 죽여(竹茹)Kill (竹茹) Phyllostachys bambusoides Phyllostachys bambusoides Clematidis RadixClematidis radix 위령선(威靈仙)Maternity Line Clematis terniflora var. Clematis terniflora var. Coix seed Coix seed 의이인(薏苡仁)Ui-in Coix lacryma-jobi L. varCoix lacryma-jobi L. var Corydalis TuberCorydalis tuber 현호색(玄胡索)Hyunho Color Corydalis ternate NakaiCorydalis ternate Nakai Taraxaci Herba Taraxaci Herba 포공영(蒲公英)Pogongyoung Taraxacum platycarpum Dahist.Taraxacum platycarpum Dahist. Citrus Unshiu PeelCitrus unshiu peel 진피(陣皮)Dermis Citrus unshiu S.Marcov.Citrus unshiu S. Marcov. Ciboule RootCiboule root 총백(蔥白)Chongbaek Allium fistulosum L.Allium fistulosum L. Forsythia FruitForsythia Fruit 연교(連翹)Fellowship Forsythia koreana NakaiForsythia koreana Nakai HoelenHoelen 백복령(白茯笭)Paekbokyeong (白 茯 笭) Poria cocos WolfPoria cocos wolf Honeysuckle FlowerHoneysuckle flower 금은화(金銀花)Gold Silver Flower Lonicera japonica Thunberg Lonicera japonica Thunberg Poncirus FruitPoncirus fruit 지실(枳實)Jisil Poncirus trifoliataPoncirus trifoliata Kalopanax CortexKalopanax Cortex 해동피(海桐皮)Haedong Blood Kalopanax septemlobus Koidz.Kalopanax septemlobus Koidz. Licorice rootLicorice root 감초(甘草)Licorice Glycyrrhiza uralensis Fisch Glycyrrhiza uralensis Fisch Mustard seed Mustard seed 백개자(白芥子)White Dog (白芥子) Sinapis alba Sinapis alba MyrrhMyrrh 몰약(沒藥)Myrrh Commiphora molmol EnglerCommiphora molmol Engler Chaenomelis FructusChaenomelis Fructus 목과(木瓜)Tree Chaenomeles sinensis KoehneChaenomeles sinensis Koehne Safflower Safflower 홍화(紅花)Safflower Carthamus tinctorius L.Carthamus tinctorius L. Schizonepetae spicaSchizonepetae spica 형개(荊芥)Brother-in-law Schizonepeta tenuifolia Var.Schizonepeta tenuifolia Var. Siegesbeckiae HerbaSiegesbeckiae Herba 희렴Celebration Siegesbeckia glabrescens MakinoSiegesbeckia glabrescens Makino Actinidiae FructusActinidiae fructus 목천료(木天蓼)Mokcheon-ryo Actinidia polygama MaximActinidia polygama Maxim Cnidium RhizomeCnidium Rhizome 천궁(川芎)Cheonggung Cnidium officinale MakinoCnidium officinale Makino Achyranthes RootAchyranthes root 우슬(牛膝)Wedge Achyranthes bidentataAchyranthes bidentata

각 약재를 표 2의 용량에 맞게 삼베 자루에 모두 담아(1,420g) 물(정제수) 13ℓ를 넣고 무압력추출기(TOWER-KS220, Kyungseo, Korea)로 100 ~ 105℃에서 3시간 30분 동안 추출하였다. 추출액은 여과기를 거쳐 자동 스텐딩 팩 포장기(DONGJIN, Korea)로 이송하여 다시 110℃까지 가열(살균)한 후 폴리에틸렌 포장지에 주입 포장하였다.Each medicine was put in burlap sacks according to the capacity of Table 2 (1,420g), and 13 liters of water (purified water) was added and extracted with a pressureless extractor (TOWER-KS220, Kyungseo, Korea) at 100-105 ° C for 3 hours 30 minutes. . The extract was transferred to an automatic standing pack packing machine (DONGJIN, Korea) through a filter and heated (sterilized) to 110 ° C., and then injected and packed into polyethylene packaging.

연번Serial number 약재명Medicinal name 용량(g)Capacity (g) 비율(%)ratio(%) 1One 황금Gold 200200 14.0914.09 22 금은화Gold silver 150150 10.5610.56 33 목천료Neck charge 100100 7.047.04 44 몰약Myrrh 8080 5.635.63 55 희렴Celebration 7070 4.934.93 66 목과Neck and neck 7070 4.934.93 77 백지blank 7070 4.934.93 99 형개Mold 7070 4.934.93 1010 지실Basement 7070 4.934.93 88 해동피Sea tangle 6060 4.234.23 1212 포공영Poongyoung 4545 3.173.17 1616 위령선A lieutenant ship 4545 3.173.17 2323 죽여Kill 4545 3.173.17 2424 현호색Corydalis 4545 3.173.17 1111 홍화Safflower 4040 2.822.82 1515 천궁Celestial 4040 2.822.82 2020 우슬The 4040 2.822.82 1414 창출Creation 3030 2.122.12 1818 진피dermis 3030 2.122.12 1919 백출Boiling 3030 2.122.12 2121 연교Abalone 1010 0.70.7 1717 건지황Guernsey 1010 0.70.7 1313 백복령Baekbokryung 1010 0.70.7 2222 감초licorice 1010 0.70.7 2525 길경Gakyung 1010 0.70.7 2626 독활Solo 1010 0.70.7 2727 의인righteous person 1010 0.70.7 2828 백개자A hundred 1010 0.70.7 2929 총백Total back 1010 0.70.7 합계Sum 14201420 100100

< 29가지 약재 수추출물의 효과 검증 ><Effect of 29 Medicinal Herb Extracts>

상기 29가지 약재 수추출물의 통풍에 대한 효과를 실험을 통해 검증하였다.
The effects on the gout of the 29 medicinal herb extracts were verified through experiments.

총 페놀 함량Total phenol content

페놀성 화합물은 식물의 2차 대사 산물의 주요 물질로서 수산기를 가지는 방향족 화합물을 총칭한다. 페놀성 화합물이 산화반응을 억제시킬 수 있는 것은 페놀이 수소원자를 라디칼에 제공하여 라디칼을 안정하게 만들고, 공명 혼성체를 형성할 수 있으므로 비교적 안정하여 산소와 반응이 어려워서 유리 라디칼을 안정화시키기 때문이다. 또한 페놀 성분의 항산화 활성은 구조에 따라 차이가 있는 것으로 알려져 있으나 일반적으로 총 페놀 함량과 식물성분의 항산화 활성이 상관관계가 있는 것으로 보고되어 있어 gallic acid를 표준용액으로 하여 작성한 검정곡선으로부터 추출물의 페놀 물질 함량을 분석하였다.Phenolic compounds collectively refer to aromatic compounds having hydroxyl groups as main substances of the plant's secondary metabolites. The phenolic compound can inhibit the oxidation reaction because the phenol can provide hydrogen atoms to the radicals to stabilize the radicals and form resonance hybrids, which is relatively stable and difficult to react with oxygen to stabilize the free radicals. . In addition, the antioxidant activity of the phenolic component is known to be different depending on the structure, but in general, it is reported that the total phenolic content and the antioxidant activity of the plant component is correlated, so the extract phenol from the calibration curve prepared using gallic acid as a standard solution Material content was analyzed.

총 페놀 함량은 Gutfinger의 방법을 변형하여 측정하였다. 즉, 추출물을 10배로 희석한 후 1㎖를 취하여 2%(w/v) Na2CO3용액 1㎖를 가하고 3분간 방치한 후, 50% Folin-Ciocalteu 시약 0.2㎖를 첨가하고 반응시켜 30분간 상온에서 방치하였다. 이 혼합액을 10분간 13,400×g에서 원심분리한 후, 상등액 1㎖를 취하여 750 nm에서 흡광도를 측정하였다. 총 페놀 함량은 gallic acid를 이용하여 작성한 표준곡선과 비교하여 gallic acid 당량(GAL)/㎖로 나타내었다.Total phenolic content was determined by modifying Gutfinger's method. That is, after diluting the extract 10 times, 1 ml was taken, 1 ml of 2% (w / v) Na 2 CO 3 solution was added thereto, and left for 3 minutes. Then, 0.2 ml of 50% Folin-Ciocalteu reagent was added and reacted for 30 minutes. It was left at room temperature. The mixture was centrifuged at 13,400 x g for 10 minutes, and then 1 ml of the supernatant was taken and absorbance was measured at 750 nm. The total phenol content was expressed as gallic acid equivalent (GAL) / mL compared to the standard curve prepared with gallic acid.

이의 결과 본 발명 수추출물의 총 페놀 함량은 1.50±0.05mg GAL/㎖로 높은 수치를 나타냈다.
As a result, the total phenolic content of the water extract of the present invention showed a high value of 1.50 ± 0.05 mg GAL / ml.

DPPH 라디칼 소거능DPPH radical scavenging ability

전자공여능 측정에 사용되는 DPPH(1-dihpenyl-2-picrylhydrazyl)는 화학적으로 유도되는 비교적 안정한 radical로 짙은 보라색을 띄는데, 아스코르빈산, 토코페롤, polyhydroxy 방향족 화합물, 방향족 아민류 등 항산화 활성이 있는 물질에 의해 전자나 수소를 받아 환원되어, 짙은 보랏빛이 탈색되어 안정한 화합물로 변화하여 노란빛을 띄게 된다. 이때 탈색되는 정도가 항산화능을 나타내는 척도가 된다고 알려져 있다.DPPH (1-dihpenyl-2-picrylhydrazyl), which is used for the measurement of electron donating ability, is a relatively stable radical that is chemically derived and has a deep purple color. It is reduced by receiving electrons or hydrogen, and the dark purple color is changed to a stable compound to give a yellowish color. At this time, the degree of discoloration is known to be a measure of antioxidant capacity.

DPPH 라디칼 소거능은 Jeong 등의 방법에 준하여 10배로 희석한 추출물 0.1㎖에 0.041mM DPPH 용액 0.9㎖를 가한 후 상온에서 30분간 반응시켜 517nm에서 흡광도를 측정하였다. 각 시료의 DPPH 라디칼 소거능은 아래의 식으로 계산하여 백분율로 나타내었다.DPPH radical scavenging ability was measured by adding 0.941 of 0.041 mM DPPH solution to 0.1 ml of the extract diluted 10-fold in accordance with Jeong's method and reacting at room temperature for 30 minutes to measure absorbance at 517 nm. DPPH radical scavenging ability of each sample was expressed as a percentage calculated by the following equation.

[계산식][formula]

DPPH 라디칼 소거능(%) =

Figure 112013075479875-pat00001
DPPH radical scavenging activity (%) =
Figure 112013075479875-pat00001

10배 희석한 본 발명 추출물의 DPPH 라디칼 소거능은 93.46±0.13%로, 100㎍/㎖의 L-ascorbic acid(89.38±1.52%)과 비교했을 때보다 높은 활성을 나타내었다.
The DPPH radical scavenging ability of the extract of the present invention diluted 10-fold was 93.46 ± 0.13%, which was higher than that of 100 μg / ml L-ascorbic acid (89.38 ± 1.52%).

ABTS 라디칼 소거능ABTS radical scavenging ability

ABTS assay은 양이온 라디칼을 소거하는 것으로 자유라디칼을 소거하는 DPPH assay와 차이를 가지며, 라디칼 특유의 청록색이 탈색되는 것을 이용하여 항산화력을 측정하는 방법이다.ABTS assay is different from DPPH assay that eliminates free radicals by eliminating cationic radicals, and it is a method to measure antioxidant power by decolorizing blue-green color.

ABTS 라디칼 소거능은 Pellegrini 등의 방법에 따라 측정하였다. 10배로 희석한 추출물 100㎕에 0.1M의 phosphate buffer(pH 5.0) 100㎕와 10mM의 hydrogen peroxide 20㎕를 가하고 이 혼합물을 37℃에서 5분간 예비 반응을 시켰다. 이 반응물에 1.25mM의 ABTS와 peroxidase(1U/㎖)를 각각 30㎕ 넣고 다시 37℃에서 10분간 반응시킨 후, 405nm에서 Multiplate Reader(Sunrise RC/TS/TS Color - TC/TW/BC/6 Filter, Tecan Austria GmbH, Austria)를 이용하여 흡광도를 측정하였다.ABTS radical scavenging ability was measured according to the method of Pellegrini et al. To 100 μl of the extract diluted 10-fold, 100 μl of 0.1 M phosphate buffer (pH 5.0) and 20 μl of 10 mM hydrogen peroxide were added, and the mixture was preliminarily reacted at 37 ° C. for 5 minutes. Add 30 μl of 1.25 mM ABTS and peroxidase (1U / mL) to the reaction, and react for 10 minutes at 37 ° C. Then, at 405 nm, use Multiplate Reader (Sunrise RC / TS / TS Color-TC / TW / BC / 6 Filter). , Tecan Austria GmbH, Austria) was used to measure the absorbance.

[계산식][formula]

ABTS 라디칼 소거능(%) =

Figure 112013075479875-pat00002
ABTS radical scavenging activity (%) =
Figure 112013075479875-pat00002

10배 희석한 본 발명 추출물의 ABTS 라디칼 소거능을 측정한 결과 89.82±0.16%로 나타났다. 대조구인 L-ascorbic acid는 100㎍/㎖에서 95.66%의 활성을 보였다.
The ABTS radical scavenging ability of the extract of the present invention diluted 10-fold was 89.82 ± 0.16%. The control group, L-ascorbic acid, showed 95.66% of activity at 100㎍ / ㎖.

XanthineXanthine oxidaseoxidase 저해 활성 Inhibitory activity

Xanthine oxidase는 생체 내 퓨린 대사에 관여하는 효소로서 xanthine 또는 hypoxanthine으로부터 요산를 형성하며, 요산이 과도하게 생산되어 혈장 내에서 증가되면 관절이나 관절 주위 조직 및 신장 등에 침착되어 염증을 일으키고, 이로 인하여 통증 및 신장 질환을 일으킨다고 알려져 있다.Xanthine oxidase is an enzyme that is involved in purine metabolism in vivo and forms uric acid from xanthine or hypoxanthine, and when uric acid is excessively produced and increased in plasma, it is deposited on joints, tissues and kidneys and causes inflammation, resulting in pain and kidneys. It is known to cause disease.

Xanthine oxidase 저해 활성은 Sirpe와 corte의 방법에 따라 실시하였다. 5배로 희석한 추출액 0.1㎖와 0.1M potassium phosphate buffer(pH 7.5) 0.6㎖에 xanthine 2mM을 녹인 기질액 0.2㎖를 첨가하였다. 여기에 xanthine oxidase(0.2 U/㎖) 0.1㎖를 가하여 37℃에서 5분간 반응시킨 후 1N HCl 1㎖를 가하여 반응을 정지시킨 후, 반응액 중에 생성된 uric acid를 흡광도 292nm에서 측정하였다. 추출액에 대한 xanthine oxidase 저해 활성은 시료 첨가구와 무첨가구의 흡광도 감소율을 백분율(%)로 나타내었으며, 대조군으로 추출액 대신 아스코르브산을 이용하여 동일한 방법으로 xanthine oxidase 저해 활성을 측정하였다.Xanthine oxidase inhibitory activity was performed according to the method of Sirpe and corte. 0.1 ml of 5-fold extract and 0.6 ml of 0.1 M potassium phosphate buffer (pH 7.5) were added to 0.2 ml of substrate solution in which xanthine 2 mM was dissolved. After 0.1 ml of xanthine oxidase (0.2 U / ml) was added thereto and reacted at 37 ° C. for 5 minutes, 1 ml of 1N HCl was added to stop the reaction, and then the uric acid generated in the reaction solution was measured at an absorbance of 292 nm. The xanthine oxidase inhibitory activity of the extract was expressed as a percentage (%) of the absorbance of the sample addition and no addition. The xanthine oxidase inhibitory activity was measured by the same method using ascorbic acid instead of the extract as a control.

5배 희석한 본 발명 추출물의 xanthine oxidase 저해 활성은 19.28±1.20%로 나타났다. 이는 100㎍/㎖의 L-ascorbic acid(11.45±1.21%)과 비교했을 때 보다 높은 활성이다.The xanthine oxidase inhibitory activity of the extract of the present invention diluted five-fold was 19.28 ± 1.20%. This is higher activity compared to 100 μg / ml L-ascorbic acid (11.45 ± 1.21%).

이상의 결과로 본 발명의 추출물이 xanthine oxidase 저해 활성을 가지며, 따라서 통풍 및 xanthine oxidase에 의해 유도되는 질병의 치료 및 개선에 효과적일 것으로 기대된다.
As a result, the extract of the present invention has xanthine oxidase inhibitory activity, and thus is expected to be effective for the treatment and improvement of diseases induced by gout and xanthine oxidase.

통계 처리Statistical processing

모든 실험은 3회 반복으로 이루어졌으며, 그 평균값은 SPSS software(Ver. 12)를 사용하여 General Linear Model의 방법에 따라 처리하였다. 각 항목에 따라 백분율과 평균치±표준오차를 구하였으며, 모든 처리값의 차이는 신뢰수준 95%(p<0.05)로 비교하여 분석되었다.
All experiments were repeated three times, and the average value was processed according to the method of General Linear Model using SPSS software (Ver. 12). Percentage and mean ± standard error were calculated according to each item, and the difference of all treatment values was analyzed by comparing with 95% confidence level (p <0.05).

실험간 상관 관계Correlation between experiments

분석한 총 페놀 함량, DPPH 라디칼 소거능, ABTS 라디칼 소거능 그리고 xanthine oxidase 저해 활성 사이의 상관관계를 비교한 결과, 총 페놀 함량은 DPPH 라디칼 소거능, ABTS 라디칼 소거능 그리고 xanthine oxidase 저해 활성 간에 높은 상관 관계를 보였으나, DPPH 라디칼 소거능은 xanthine oxidase 저해 활성과 상대적으로 낮은 상관 관계를 보였다. 이는 효소의 저해 활성과 라디칼 소거능 간의 상관관계는 찾을 수 없지만 Xanthine oxidase를 강하게 저해하는 ellagic acid와 같은 탄닌 및 탄닌 관련 물질들이 라디칼 소거능도 가진다는 보고에 따라 식용 약초 추출물에 의해 Xanthine oxidase가 라디칼 소거능의 영향보다 탄닌 및 그 관련 물질의 영향에 의해 저해되었을 것이라 추측된다.
The correlation between the total phenolic content, DPPH radical scavenging activity, ABTS radical scavenging activity and xanthine oxidase inhibitory activity was analyzed. , DPPH radical scavenging activity was relatively low correlated with xanthine oxidase inhibitory activity. Although there is no correlation between the inhibitory activity and the radical scavenging activity of the enzyme, it is reported that tannin and tannin-related substances such as ellagic acid, which strongly inhibit Xanthine oxidase, also have radical scavenging ability. It is presumed that this would be inhibited by the effects of tannins and their related substances rather than the effects.

< 통풍환자를 대상으로 한 29가지 약재 수추출물의 효과 검증 ><Effectiveness of 29 medicinal herb extracts for gout patients>

전문의로부터 통풍을 진단받은 환자에게 100㎖ 단위로 포장한 엑기스 형태의 29가지 약재 수추출물을 제공하고, 성인 1인(몸무게 평균 약 70㎏정도, 대부분 통풍 환자는 여윈 사람이 없음)이 하루에 2회(오전, 오후) 30일간 복용하도록 하였다. 이를 원칙으로 하고, 통증이 있을 때에는 필요에 의해 1팩 내지 2팩을 복용토록 하여 통풍에 따른 통증의 완화 효과를 조사하였다.The patient was diagnosed with gout and provided with 29 extracts of extracts in 100ml increments. One adult (weight average 70kg, most patients with gout) had 2 per day. Take 30 days (morning, afternoon). As a rule, when there is pain, 1 to 2 packs are taken as necessary to investigate the relief of pain caused by gout.

통풍 환자 12명을 대상으로 하였으며, 통증 완화 효과를 5점 척도법으로 측정하였다(5, 통증이 많이 완화되었다; 4, 통증이 완화되었다; 3, 차이가 없다; 2, 통증이 악화되었다; 1, 통증이 매우 악화되었다).Twelve patients with gout were measured and pain relief was measured on a five-point scale (5, pain was alleviated; 4, pain was alleviated; 3, no difference; 2, pain was worsening; 1, Pain was very worse).

환자patient 통증완화정도Pain relief 1One 55 22 55 33 55 44 55 55 55 66 55 77 55 88 33 99 44 1010 33 1111 44 1212 55 합계Sum 5454 평균Average 4.54.5

평가 결과, 표 3에서와 같이 본 발명의 추출물을 복용함에 따라 대부분 환자가 통증이 완화되는 것을 느낀 것으로 나타났다.
As a result of the evaluation, as shown in Table 3, most patients felt that the pain was relieved by taking the extract of the present invention.

Claims (9)

황금, 금은화, 목천료, 몰약, 희렴, 목과, 백지, 형개, 지실, 해동피, 포공영, 위령선, 죽여, 현호색, 홍화, 천궁, 우슬, 창출, 진피, 백출, 연교, 건지황, 백복령, 감초, 길경, 독활, 의이인, 백개자 및 총백의 수추출물을 유효성분으로 함유하는 통풍 예방 또는 치료용 약제학적 조성물.Golden, silver and gold, myrrh, myrrh, bliss, tree and white paper, hyungge, jisil, haedongpi, pogongyoung, lieutenant ship, kill, hyunho colour, safflower, cheongung, wolden, creation, dermis, baekryeok, kyoji, gunjihwang, baekbokyeong, licorice , Venom, uiyiin, gyeokgwa and ginseng extracts containing the water extract as an active ingredient pharmaceutical composition for preventing or treating gout. 제 1항에 있어서,
상기 수추출물은
황금 10 내지 18중량%, 금은화 7 내지 14중량%, 목천료 5 내지 9중량%, 몰약 4 내지 8중량%, 희렴 3 내지 7중량%, 목과 3 내지 7중량%, 백지 3 내지 7중량%, 형개 3 내지 7중량%, 지실 3 내지 7중량%, 해동피 3 내지 6%, 포공영 2 내지 4중량%, 위령선 2 내지 4중량%, 죽여 2 내지 4중량%, 현호색 2 내지 4중량%, 홍화 2 내지 4중량%, 천궁 2 내지 4중량%, 우슬 2 내지 4중량%, 창출 1 내지 3중량%, 진피 1 내지 3중량%, 백출 1 내지 3중량%, 연교 0.5 내지 1중량%, 건지황 0.5 내지 1중량%, 백복령 0.5 내지 1중량%, 감초 0.5 내지 1중량%, 길경 0.5 내지 1중량%, 독활 0.5 내지 1중량%, 의이인 0.5 내지 1중량%, 백개자 0.5 내지 1중량% 및 총백 0.5 내지 1중량%의 혼합물로부터 수추출한 것임을 특징으로 하는 통풍 예방 또는 치료용 약제학적 조성물.
The method of claim 1,
The water extract is
10 to 18% by weight of gold, 7 to 14% by weight of silver and silver, 5 to 9% by weight, molar about 4 to 8%, 3 to 7% by weight, 3 to 7% by weight of neck, 3 to 7% by weight of white paper, 3 to 7% by weight, 3 to 7% by weight of fruit, 3 to 6% by thawing blood, 2 to 4% by weight, 2 to 4% by weight of gastric glands, 2 to 4% by weight, 2 to 4% by weight of magenta color, safflower 2 To 4% by weight, 2 to 4% by weight, 2 to 4% by weight, 1 to 3% by weight, 1 to 3% by weight, 1 to 3% by weight of dermis, 1 to 3% by weight, 0.5 to 1% by weight, 0.5 to 1% of dried fish 1% by weight, Baekbokyeong 0.5-1% by weight, licorice 0.5-1% by weight, 0.5-1% by weight length, 0.5-1% by weight, Euiin 0.5-1% by weight, 0.5-1% by weight, and 0.5-1 by weight A pharmaceutical composition for preventing or treating gout, characterized in that it is extracted from the mixture by weight.
제 2항에 있어서,
상기 수추출물은
상기 혼합물에 5 내지 20배 중량의 물을 첨가하고 90 내지 110℃에서 2 내지 5시간 추출하여 수득한 추출액인 것을 특징으로 하는 통풍 예방 또는 치료용 약제학적 조성물.
3. The method of claim 2,
The water extract is
A pharmaceutical composition for preventing or treating gout, wherein the extract is obtained by adding 5 to 20 times the weight of water to the mixture and extracting it at 90 to 110 ° C. for 2 to 5 hours.
황금, 금은화, 목천료, 몰약, 희렴, 목과, 백지, 형개, 지실, 해동피, 포공영, 위령선, 죽여, 현호색, 홍화, 천궁, 우슬, 창출, 진피, 백출, 연교, 건지황, 백복령, 감초, 길경, 독활, 의이인, 백개자 및 총백의 수추출물을 유효성분으로 함유하는 통풍 예방 또는 개선용 기능식품.Golden, silver and gold, myrrh, myrrh, bliss, tree and white paper, hyungge, jisil, haedongpi, pogongyoung, lieutenant ship, kill, hyunho colour, safflower, cheongung, wolden, creation, dermis, baekryeok, kyoji, gunjihwang, baekbokyeong, licorice , Ginseng, uiyiin, ginseng and ginseng extracts containing ginseng extract as an active ingredient for preventing or improving functional foods. 제 4항에 있어서,
상기 수추출물은
황금 10 내지 18중량%, 금은화 7 내지 14중량%, 목천료 5 내지 9중량%, 몰약 4 내지 8중량%, 희렴 3 내지 7중량%, 목과 3 내지 7중량%, 백지 3 내지 7중량%, 형개 3 내지 7중량%, 지실 3 내지 7중량%, 해동피 3 내지 6%, 포공영 2 내지 4중량%, 위령선 2 내지 4중량%, 죽여 2 내지 4중량%, 현호색 2 내지 4중량%, 홍화 2 내지 4중량%, 천궁 2 내지 4중량%, 우슬 2 내지 4중량%, 창출 1 내지 3중량%, 진피 1 내지 3중량%, 백출 1 내지 3중량%, 연교 0.5 내지 1중량%, 건지황 0.5 내지 1중량%, 백복령 0.5 내지 1중량%, 감초 0.5 내지 1중량%, 길경 0.5 내지 1중량%, 독활 0.5 내지 1중량%, 의이인 0.5 내지 1중량%, 백개자 0.5 내지 1중량% 및 총백 0.5 내지 1중량%의 혼합물로부터 수추출한 것임을 특징으로 하는 통풍 예방 또는 개선용 기능식품.
5. The method of claim 4,
The water extract is
10 to 18% by weight of gold, 7 to 14% by weight of silver and silver, 5 to 9% by weight, molar about 4 to 8%, 3 to 7% by weight, 3 to 7% by weight of neck, 3 to 7% by weight of white paper, 3 to 7% by weight, 3 to 7% by weight of fruit, 3 to 6% by thawing blood, 2 to 4% by weight, 2 to 4% by weight of gastric glands, 2 to 4% by weight, 2 to 4% by weight of magenta color, safflower 2 To 4% by weight, 2 to 4% by weight, 2 to 4% by weight, 1 to 3% by weight, 1 to 3% by weight, 1 to 3% by weight of dermis, 1 to 3% by weight, 0.5 to 1% by weight, 0.5 to 1% of dried fish 1% by weight, Baekbokyeong 0.5-1% by weight, licorice 0.5-1% by weight, 0.5-1% by weight length, 0.5-1% by weight, Euiin 0.5-1% by weight, 0.5-1% by weight, and 0.5-1 by weight Functional food for preventing or improving gout, characterized in that water extracted from the mixture by weight.
제 5항에 있어서,
상기 수추출물은
상기 혼합물에 5 내지 20배 중량의 물을 첨가하고 90 내지 110℃에서 2 내지 5시간 추출하여 수득한 추출액인 것을 특징으로 하는 통풍 예방 또는 개선용 기능식품.
6. The method of claim 5,
The water extract is
Functional food for preventing or improving gout, characterized in that the extract obtained by adding 5 to 20 times the weight of water to the mixture and extracted for 2 to 5 hours at 90 to 110 ℃.
황금, 금은화, 목천료, 몰약, 희렴, 목과, 백지, 형개, 지실, 해동피, 포공영, 위령선, 죽여, 현호색, 홍화, 천궁, 우슬, 창출, 진피, 백출, 연교, 건지황, 백복령, 감초, 길경, 독활, 의이인, 백개자 및 총백의 수추출물을 유효성분으로 함유하는 통풍 예방 또는 개선용 식품첨가물.Golden, silver and gold, myrrh, myrrh, bliss, tree and white paper, hyungge, jisil, haedongpi, pogongyoung, lieutenant ship, kill, hyunho colour, safflower, cheongung, wolden, creation, dermis, baekryeok, kyoji, gunjihwang, baekbokyeong, licorice , Ginseng, uiyiin, ginseng and ginseng extracts containing ginseng extract as an active ingredient as an active ingredient. 제 7항에 있어서,
상기 수추출물은
황금 10 내지 18중량%, 금은화 7 내지 14중량%, 목천료 5 내지 9중량%, 몰약 4 내지 8중량%, 희렴 3 내지 7중량%, 목과 3 내지 7중량%, 백지 3 내지 7중량%, 형개 3 내지 7중량%, 지실 3 내지 7중량%, 해동피 3 내지 6%, 포공영 2 내지 4중량%, 위령선 2 내지 4중량%, 죽여 2 내지 4중량%, 현호색 2 내지 4중량%, 홍화 2 내지 4중량%, 천궁 2 내지 4중량%, 우슬 2 내지 4중량%, 창출 1 내지 3중량%, 진피 1 내지 3중량%, 백출 1 내지 3중량%, 연교 0.5 내지 1중량%, 건지황 0.5 내지 1중량%, 백복령 0.5 내지 1중량%, 감초 0.5 내지 1중량%, 길경 0.5 내지 1중량%, 독활 0.5 내지 1중량%, 의이인 0.5 내지 1중량%, 백개자 0.5 내지 1중량% 및 총백 0.5 내지 1중량%의 혼합물로부터 수추출한 것임을 특징으로 하는 통풍 예방 또는 개선용 식품첨가물.
8. The method of claim 7,
The water extract is
10 to 18% by weight of gold, 7 to 14% by weight of silver and silver, 5 to 9% by weight, molar about 4 to 8%, 3 to 7% by weight, 3 to 7% by weight of neck, 3 to 7% by weight of white paper, 3 to 7% by weight, 3 to 7% by weight of fruit, 3 to 6% by thawing blood, 2 to 4% by weight, 2 to 4% by weight of gastric glands, 2 to 4% by weight, 2 to 4% by weight of magenta color, safflower 2 To 4% by weight, 2 to 4% by weight, 2 to 4% by weight, 1 to 3% by weight, 1 to 3% by weight, 1 to 3% by weight of dermis, 1 to 3% by weight, 0.5 to 1% by weight, 0.5 to 1% of dried fish 1% by weight, Baekbokyeong 0.5-1% by weight, licorice 0.5-1% by weight, 0.5-1% by weight length, 0.5-1% by weight, Euiin 0.5-1% by weight, 0.5-1% by weight, and 0.5-1 by weight A food additive for preventing or improving gout, characterized in that it is extracted from the mixture by weight.
제 8항에 있어서,
상기 수추출물은
상기 혼합물에 5 내지 20배 중량의 물을 첨가하고 90 내지 110℃에서 2 내지 5시간 추출하여 수득한 추출액인 것을 특징으로 하는 통풍 예방 또는 개선용 식품첨가물.
The method of claim 8,
The water extract is
The food additive for preventing or improving gout, characterized in that the extract obtained by adding 5 to 20 times the weight of water to the mixture and extracted for 2 to 5 hours at 90 to 110 ℃.
KR1020130098557A 2013-08-20 2013-08-20 Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient KR101346281B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020130098557A KR101346281B1 (en) 2013-08-20 2013-08-20 Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020130098557A KR101346281B1 (en) 2013-08-20 2013-08-20 Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient

Publications (1)

Publication Number Publication Date
KR101346281B1 true KR101346281B1 (en) 2013-12-31

Family

ID=49989351

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020130098557A KR101346281B1 (en) 2013-08-20 2013-08-20 Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient

Country Status (1)

Country Link
KR (1) KR101346281B1 (en)

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103877438A (en) * 2014-03-13 2014-06-25 广西中医药大学 Traditional Chinese medicine preparation for treating gout and production method thereof
CN104013876A (en) * 2014-05-20 2014-09-03 王伟伟 Traditional Chinese medicine composition for treating pelvic inflammatory disease
CN104398863A (en) * 2014-10-13 2015-03-11 洛阳御平国生物科技有限公司 Traditional Chinese medicine preparation aiming to gout
CN104587316A (en) * 2014-12-30 2015-05-06 广西中医药大学 Anti-gout composition as well as preparation method and application thereof
CN104758722A (en) * 2015-03-26 2015-07-08 柳晖 Traditional Chinese medicine composition for treating gout
CN104800696A (en) * 2015-05-13 2015-07-29 宋小冰 Traditional Chinese medicine preparation for treating gout
CN104887972A (en) * 2015-07-03 2015-09-09 李军 Traditional Chinese medicine external-use agent for treating gout and preparation method for traditional Chinese medicine external-use agent
CN104888061A (en) * 2015-07-03 2015-09-09 李军 Traditional Chinese medicine medicament for treating gout and preparation method for traditional Chinese medicine medicament
CN104888060A (en) * 2015-07-03 2015-09-09 李军 Traditional Chinese medicine medicament for treating gout
CN104906382A (en) * 2015-07-03 2015-09-16 李军 Traditional Chinese medicine external preparation for treating gout and preparation method
CN104906467A (en) * 2015-07-03 2015-09-16 李军 Traditional Chinese medicine composition for treating gout and preparation method
CN106265851A (en) * 2016-08-31 2017-01-04 贵州苗侗古方民族医药开发有限公司 A kind of Seedling tea of effective reduction uric acid
KR101715520B1 (en) 2015-11-12 2017-03-13 한림대학교 산학협력단 The pharmaceutical compositions for the treatment of gout
CN107158305A (en) * 2017-06-03 2017-09-15 刘进池 Treat the Chinese medicine preparation of gout
CN107343934A (en) * 2017-09-12 2017-11-14 杨文旭 A kind of Chinese medicine composition for treating gout, Chinese medicine preparation and preparation method thereof
CN107715014A (en) * 2017-10-31 2018-02-23 南宁市共健源健康科技有限公司 A kind of Chinese medicine composition for gout and preparation method thereof
CN107898977A (en) * 2017-12-29 2018-04-13 南宁市共健源健康科技有限公司 Anti-trioxypurine Chinese medicine preparation
CN107898978A (en) * 2017-12-29 2018-04-13 南宁市共健源健康科技有限公司 Chinese medicine composition containing lopseed and preparation method thereof
CN108096502A (en) * 2018-01-20 2018-06-01 南阳仲景百信医药科技有限公司 A kind of anti-trioxypurine alternative tea and preparation method thereof
KR20190033828A (en) * 2017-09-22 2019-04-01 한국 한의학 연구원 Compositions for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising herbal extracts
CN112023019A (en) * 2020-09-15 2020-12-04 上海健康医学院 Medicine containing active polysaccharide with effect of reducing uric acid and preparation method thereof
CN112717078A (en) * 2021-01-26 2021-04-30 上海中医药大学 Traditional Chinese medicine composition, preparation thereof, preparation method and application
KR102251380B1 (en) * 2020-11-30 2021-05-14 주식회사 더원푸드 Method for producing pickle sauce using sprout ginseng and plant extract
KR20210155046A (en) 2020-06-15 2021-12-22 이영희 Method for manufacturing Island Thistle Fermented pickles
KR20220040617A (en) 2020-09-24 2022-03-31 롯데푸드 주식회사 Composition for inhibiting gout comprising mixture of Scutellaria baicalensis extract and nelumbinis folium extract as active ingredient

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100492470B1 (en) 2003-05-20 2005-06-02 윤병원 Composition for treating and preventing gout
KR100759468B1 (en) 2006-06-26 2007-10-04 한국생명공학연구원 Composition for prevention and treatment of anti-gout comprising purple pigments isolated from purple sweet-potato
KR100989112B1 (en) 2009-12-31 2010-10-26 권태선 Composition for medical treatment and gout prevention

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100492470B1 (en) 2003-05-20 2005-06-02 윤병원 Composition for treating and preventing gout
KR100759468B1 (en) 2006-06-26 2007-10-04 한국생명공학연구원 Composition for prevention and treatment of anti-gout comprising purple pigments isolated from purple sweet-potato
KR100989112B1 (en) 2009-12-31 2010-10-26 권태선 Composition for medical treatment and gout prevention

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103877438A (en) * 2014-03-13 2014-06-25 广西中医药大学 Traditional Chinese medicine preparation for treating gout and production method thereof
CN104013876A (en) * 2014-05-20 2014-09-03 王伟伟 Traditional Chinese medicine composition for treating pelvic inflammatory disease
CN104398863A (en) * 2014-10-13 2015-03-11 洛阳御平国生物科技有限公司 Traditional Chinese medicine preparation aiming to gout
CN104587316A (en) * 2014-12-30 2015-05-06 广西中医药大学 Anti-gout composition as well as preparation method and application thereof
CN104758722A (en) * 2015-03-26 2015-07-08 柳晖 Traditional Chinese medicine composition for treating gout
CN104800696A (en) * 2015-05-13 2015-07-29 宋小冰 Traditional Chinese medicine preparation for treating gout
CN104800696B (en) * 2015-05-13 2019-01-18 宋小冰 A kind of Chinese materia medica preparation for treating gout
CN104887972A (en) * 2015-07-03 2015-09-09 李军 Traditional Chinese medicine external-use agent for treating gout and preparation method for traditional Chinese medicine external-use agent
CN104888060A (en) * 2015-07-03 2015-09-09 李军 Traditional Chinese medicine medicament for treating gout
CN104906382A (en) * 2015-07-03 2015-09-16 李军 Traditional Chinese medicine external preparation for treating gout and preparation method
CN104906467A (en) * 2015-07-03 2015-09-16 李军 Traditional Chinese medicine composition for treating gout and preparation method
CN104888061A (en) * 2015-07-03 2015-09-09 李军 Traditional Chinese medicine medicament for treating gout and preparation method for traditional Chinese medicine medicament
KR101715520B1 (en) 2015-11-12 2017-03-13 한림대학교 산학협력단 The pharmaceutical compositions for the treatment of gout
CN106265851A (en) * 2016-08-31 2017-01-04 贵州苗侗古方民族医药开发有限公司 A kind of Seedling tea of effective reduction uric acid
CN107158305A (en) * 2017-06-03 2017-09-15 刘进池 Treat the Chinese medicine preparation of gout
CN107343934A (en) * 2017-09-12 2017-11-14 杨文旭 A kind of Chinese medicine composition for treating gout, Chinese medicine preparation and preparation method thereof
KR20190033828A (en) * 2017-09-22 2019-04-01 한국 한의학 연구원 Compositions for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising herbal extracts
KR102002298B1 (en) 2017-09-22 2019-07-23 한국한의학연구원 Compositions for preventing, ameliorating or treating hyperuricemia or metabolic disorders associated with hyperuricemia comprising herbal extracts
CN107715014A (en) * 2017-10-31 2018-02-23 南宁市共健源健康科技有限公司 A kind of Chinese medicine composition for gout and preparation method thereof
CN107898977A (en) * 2017-12-29 2018-04-13 南宁市共健源健康科技有限公司 Anti-trioxypurine Chinese medicine preparation
CN107898978A (en) * 2017-12-29 2018-04-13 南宁市共健源健康科技有限公司 Chinese medicine composition containing lopseed and preparation method thereof
CN108096502A (en) * 2018-01-20 2018-06-01 南阳仲景百信医药科技有限公司 A kind of anti-trioxypurine alternative tea and preparation method thereof
CN108096502B (en) * 2018-01-20 2021-02-05 南阳仲景百信医药科技有限公司 Uric acid-reducing substitutional tea and preparation method thereof
KR20210155046A (en) 2020-06-15 2021-12-22 이영희 Method for manufacturing Island Thistle Fermented pickles
CN112023019A (en) * 2020-09-15 2020-12-04 上海健康医学院 Medicine containing active polysaccharide with effect of reducing uric acid and preparation method thereof
KR20220040617A (en) 2020-09-24 2022-03-31 롯데푸드 주식회사 Composition for inhibiting gout comprising mixture of Scutellaria baicalensis extract and nelumbinis folium extract as active ingredient
KR102251380B1 (en) * 2020-11-30 2021-05-14 주식회사 더원푸드 Method for producing pickle sauce using sprout ginseng and plant extract
CN112717078A (en) * 2021-01-26 2021-04-30 上海中医药大学 Traditional Chinese medicine composition, preparation thereof, preparation method and application

Similar Documents

Publication Publication Date Title
KR101346281B1 (en) Compositions for preventing, improving or treating gout, containing extracts of twenty nine medicine plants as active ingredient
KR100574097B1 (en) Functional food compositions having the effect on eliminating an alcoholic hangover and improvement of liver function
KR101787432B1 (en) Method for manufacturing oriental medicine composition which improves menorrhagia and dysmenorrhea comprising fermented velvet antler and yeast hydrolysate
KR20120084723A (en) Antiphlogistic, antioncotic and analgesic chinese herbal composition, preparative method and usage thereof
KR101793531B1 (en) A composition and functional food comprising an combination extract of Atractylodes macrocephala KOIDZ, Morus alba L., Lycium chinensis, Euphoria lingan STEUD, Achyranthus japonica NAKAI, Eucommia ulmoides OLIV and Asparagus cochinchinensis MERR for preventing or treating postmenopause syndrome
KR100980819B1 (en) The composition comprising complex herbal extract as an active ingredient and the preparation method thereof
KR20090127523A (en) Composition for treating atopy and acne
CN102973779A (en) Traditional Chinese medicine composition for treating seborrheic dermatitis and acne and preparation method thereof
CN104906390A (en) Medicine for treating occupational chronic lead poisoning caused by spleen-stomach disharmony and preparation method
CN104474028B (en) Ointment for the treatment of skin pruritus and preparation method thereof
KR100376307B1 (en) Healthy food composition for preventing and treatmenting constipation
KR20130009901A (en) Health food composition for improving blood circulation, strengthening energy and preventing osteoporosis
KR20020078467A (en) Drink for tonic liver and Manufacture process the same.
CN104739941A (en) Traditional Chinese medicine preparation for treating kidney-Yang deficiency type aciesis and preparation method thereof
KR101479096B1 (en) Health functional food comprising extracts of herbal mixture for preventing or improving edema of delivered or pregnant woman
KR20030068748A (en) Functional compositions of natural products for anti-aging effect and for inhibiting effect of growth of harmful bacteria
CN106039089A (en) Medicine for treating porcine gastroenteritis
KR102136053B1 (en) Composition for Removing Hangover Comprising Herb Extract and Beverage Thereof
KR102111836B1 (en) the natural composite with the functon of rheumatoid athritis protection and treatment
KR100522176B1 (en) Composition for improving male sexual function
KR100642801B1 (en) Anti-diabetic food composition comprising extracts from natural herbal materials and pear and process for preparing the same
CN104984237A (en) Traditional Chinese medicine composition and preparation method
WO2019142042A1 (en) Synergistic medicinal preparation for treating skin disorders like tinea versicolor
CN106310226A (en) Chinese herbal medicine compound preparation for preventing and treating piglet dysentery and preparation method thereof
KR102217732B1 (en) Composition for preventing and improving the development of premature pseudo-breast

Legal Events

Date Code Title Description
A201 Request for examination
A302 Request for accelerated examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20161223

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180927

Year of fee payment: 5

R401 Registration of restoration
FPAY Annual fee payment

Payment date: 20181213

Year of fee payment: 6

FPAY Annual fee payment

Payment date: 20191126

Year of fee payment: 7